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GENERAL INTRODUCTION 
Organic synthesis remains a dynamic and central area of organic chemistry. 
There are many new principles, strategies and methods of synthesis waiting to 
be discovered. It is the widespread belief that a key aspect of synthetic design is 
efficiency — the ability to transform readily available starting materials into target 
compounds via the shortest possible routes. 
This thesis will deal with a new synthetic approach to pyranonaphtho-
quinone antibiotics and diterpene alkaloids. 
Explanation of Thesis Format 
This thesis is written so that each part represents an article in a publishable 
form. The numbering scheme adopted for the compounds and references is 
independent in each section. 
2  
PARTI. 
NEW SYNTHETIC APPROACH TO PYRANONAPHTHOOUINONE ANTIBIOTICS 
3  
INTRODUCTION 
The useful biological activity and unique structure of pyranoquinones have 
prompted considerable synthetic attention. It is clear from an examination of their 
structures that the primary difference lies in the substitution pattern on the 
naphthoquinone subunit. Our interest in developing a common intermediate for 
all of these natural products led us to plan a new synthetic approach. 
This manuscript will detail our three step (Michael addition, oxidation and 
reduction) sequence for pyranolactone subunits and Michael addition/aldol 
condensation methodology for the production of C-glycosyl compounds. 
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HISTORICAL 
Quinones constitute an Important class of compounds that show wide-
ranging biological activities/ Many naphthoquinone-derived natural products 
show significant antibiotic and antitumor properties.3,4 Among them, the 
pyranonaphthoquinone antibiotics are a growing class of compounds which 
were isolated from various species of Stretomvces. Its important members 
include the nanaomycins (NNM), frenolicins, medermycins, granaticins, SCH-
38519, and the arizonins. 
The nanaomycin (NNM) group is the largest group in the pyranonaphtho­
quinone antibiotics. Kalafungin (1), the enantiomer of nanaomycin D (2), was 
isolated in 1968 by workers at the Upjohn company from Streptomvces 
tranashlensis strain kala (UC-5063).5.6 The absolute configuration of kalafungin 
was determined by single crystal X-ray analysis.^ 
O 
1 2 
Nanaomycin A (3), nanaomycin B (4), nanaomycin C (5), nanaomycin D (2) 
and nanaomycin E (6) were produced from S. rosa subsp. notoensis. which 
were named after the place where the soil sample was collected.®"^ 
5  
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Nanaomycin shows moderate antibacterial activity and strong activity 
against mycoplasma, as well as activity against Trichophyton Spp. in vitro. 
Hamana et al JO studied the complex dermatomycosis of cattle. With a single 
application of 100 ppm of nanaomycin A, the dermatomycosis caused by 
Trichophyton Verrucosum was healed in one month. After safety tests were 
conducted, it was approved as an antifungal antibiotic for veterinary use. 
The probable biosynthetic pathway for nanaomycin was elucidated through 
the use of a radiolabeled acetate. 11 The detailed biosynthesis of each 
component of the nanaomycin complex was studied by use of a cell-free system 
from S. rosa. Subso. Notoensis.12 Three kinds of enzymes involved in 
nanaomycin biosynthesis were characterized. 
6  
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Among them, nanaomycin D reductase, a flavoenzyme, was purified to 
homogeneity. Nanaomycin B synthase is the first enzyme known to convert an 
epoxide group to a monoalcohol. 
Recently "yellow pigment" was isolated as an intermediate of biosynthesis 
of isochromanequinone antibiotics."'3 Yellow pigment was synthesized and 
biomimetically converted to (±) nanaomycin 
OH O OH O 
O 
Yellow pigment Nanaomycin A 
Hayashi et al. proposed the mechanism of action of these antibiotics in a 
marine bacterium, Vibrio Alqinolvticus.15 
Nanaomycin A receives electrons from respiratory flavoprotein to give a 
reduced form. When reduced nanaomycin A is oxidized to nanaomycin A by 
molecular oxygen, superoxide radical (O3-) is produced. Superoxide dismutase 
present in the bacterium acts as a scavenger of 02*. but the bacterium is killed 
due to insufficient digestion and toxicity of O2' in the presence of a significant 
amount of nanaomycin A. 
The frenolicins are another subclass of pyranonaphthoquinone antibiotics. 
Frenolicin 7,16,17 deoxyfrenolicin 8,17,18 and frenolicin B (9)1® have been 
isolated and their structures determined as C-1 n-propyl analogs of the 
nanaomycins. 
8  
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The frenolicin subclass is also active against bacteria, pathogenic fungic 
and mycoplasmas. Frenolicin B is particularly effective against Eimeria tenella. a 
pathogen of concern to the poultry industry/9 
The biological activities of 9-deoxyfrenolicin B (10) are very interesting.20 
10 
Medermycin (11)21 and mederrhodin A (12)22 are pyranonaphthoquinone 
antibiotics isolated in 1983 and 1985, respectively. These compounds are 
similar to the frenolicins in absolute configuration and exhibit low acute toxicity in 
mice and appear promising as antitumor agents. 
NMez 
HQ OH O 
11 R = H 
12R = 0H 
Recently, Hopwood et al. found mederrhodin A. A gene for the enzyme from 
S. coelicolor which hydroxylates the C-6 of an actinorrhodin precursor was taken 
and ligated to plasmid vecto PIJ922 and transformed into the medermycin 
1 0  
producing strain Streptomyces sp. strain AM-7161. One of the transformants, 
with piasmid PIJ2315 carrying the gene for the hydroxyiating enzyme, produced 
a new hydroxylated medermycin named mederrhodin. Mederrhodin is the first 
antibiotic obtained by recombinant DNA technology thus far. 
11 
2 
Actinorhodin 
(Hydroxylase?) 
12 
Griseusins A (13), griseusins B (14), granaticin (15) and granaticin B (16) are 
more complex members of the pyranonaphthoquinone family. 
Griseusins A and B were isolated from Streotomvces qriseusis strain K-63 
by Tsuji et al. in 1975.23 
Granaticin was first isolated in 1957 from the culture of Streptomvces 
oliuceus.24 it is highly active against gram-positive bacteria and protozoa and 
exhibits some activity against p-388 cymphocytic leukemia in mice (T/C166% at 
1.5 mg/kg) and cytotoxicity against KB cells (ED50 1.6 ug/ml).25,26 Granaticin B 
OH O 
1 1  
shows a distinct inhibition of various transplanted tumors In rodents after 
intreperitoneai application. Granaticin has been reported to inhibit RNA 
synthesis in bacteria by the failure to charge leucyl-tRNA.27 The cytotoxicity of 
15 is attributed to inhibition of ribosomal RNA maturation.28 
OH O 
17 
SCH-38519 (17) is a novel C-glycoside isolated in 1985 .22,29 ^ inhibits 
1 2  
the growth of gram-positive and gram-negative microorganisms. The structure 
was based on NMR spectral data in combination with an X-ray crystal structure 
analysis of its hydrochloride salt. This aryl C-glycosyl compound has the phenol 
group meta to the C-glycosyl linkage unlike medermycin (11) which has the 
phenol group In the ortho position. 
O 
Arizonin A1 
18 
Arizonin A2 
19 
CH3O 
O 
Arizonin B2 
2 1  
Arizonin B1 
20  
O 
Arizonin CI 
2 2  
Arizonin C3 
23 
The arizonins are a new complex of anti-gram-positive antibiotics which was 
produced by the fermentation of Actlnoplanes arizanaensis Sp. nov. The 
1 3  
antibiotics were recovered from the fermentation broth with Amberlite XAD-7 
resin and from the mycelium by acetone lysis. UV, IR, MS and NMR spectral 
studies characterized these compounds as kalafungin-type antibiotics.30 
Pyranonaphthoquinones show characteristic biological activities and have 
in common the isochromanquinone skeleton 30. All contain the 2,3-fused 
pyranonaphthoquinone ring system in addition to alkyi and acetic acid residues. 
This basic structural type can lead to reactive alkylating agents by in vivo 
reduction, a process suggested to be responsible for the biological activity of the 
series. Their interesting biological activity is responsible for the many syntheses. 
Due to their useful biological activity, the pyranonaphthoquinones have 
received considerable attention and have become attractive synthetic objectives. 
To date, many synthetic routes to these pyranonaphthoquinones have been 
reported. The successful total syntheses of nanaomycin D, nanaomycin A, 
kalafungin, frenolicin, deoxyfrenolicin and the enantiomer of griseusin have 
involved a variety of interesting strategies. These strategies can be divided as 
follows: 
I. Reductive alkylation of naphthoquinones 
This strategy originates from Schemie's method^^ for the synthesis of 
eleutherin and isoeleutherin.32 The key step involved condensation of the 
10 
1 4  
hydroxyester 31 with acetaldehyde giving the isochroman 32, which could be 
converted into the lactone 34 by air oxidation. 
OH MeCHO 
CO2R • CO2R 
OH = 
CO2R 
OH 3 
OH O 
St. Pyrek et al. were the first to utilize this strategy in their synthesis of 
deoxynanaomycin methyl ester.33 
OH Zn/HQ 
C02Me ci^CHO 
O 
O 
C02Me 
O 
36 
The first synthesis of the natural pyranonaphthoquinone antibiotic 
nanaomycin A was achieved by Li and Ellison.34 
Compound 37, which was prepared by a multistep sequence, underwent 
acetaldehyde addition followed bytreatment with silver(l) oxide to give the cis-
pyran 38. The cis-pyran 38 was converted to nanaomycin A by methyl cleavage, 
1 5  
OMeO OMeO 
OH 
COjEt 
O 
37 
C02Et 
O 
38 
OH O OH O 
CO2H 
O 
3 
(Xo 
o 
1.% 
2. A 
(Xo 
O^^^^^^SePh 
C02Me 
(W K2CO 
^vx'v.^'\/***^C02Me ' 
39 
OH 
40 
AgjP 
0-<^C02Me 
OH O 
lvX]X..^C02Me 
41 
O 
42 
OH O = 
CO2H 
O 
1  6  
acid catalyzed isomerization and ester hydrolysis. Nanaomycin A with air in 
methanol gave a racemic mixture of kalafungin and nanaomycin D. 
The same strategy was employed by Kometani et al. in 1983.35 Oxidation 
of 39, followed by elimination and Claisen rearrangement produced 40. 
Treatment of 40 with base and oxidative cleavage of naphthofuran 41 afforded 
42, which was transformed into nanaomycin A by reactions similar to those in 
the Li and Ellison synthesis. 
II. Addition of nucleophiles to activated naphthoquinones. 
The Michael addition of a butenolide equivalent, 2-t-butoxyfuran, with 
acetylnaphthoquinone 43 gave the condensation product 44, which was then 
reductively cyclised to give 45. This strategy was discovered in 1979 in this 
laboratory and led to a synthesis of kalafungin.36 
OMeO O /—a OMeOMeO 
o o OMe 
43 44 
LAH 
OMeOMe 
OMeO 
45 
This strategy was further developed. Addition of nucleophiles to 
naphthoquinone followed by tandem Diels-Alder/retro-Claisen (DARC) reaction 
1 7  
produced the carbon skeleton. A stereoselective reduction of a hemiketal made 
this the most direct and practical synthetic route.37 
W" — 
O O-C^COgR' 
46 
7r^ — rW° 
•vAy'K.Av^COÎR' 
o o 
47 R = CI%, Pr 
III. Intramolecular alkoxide Michael addition 
The construction of the pyran moiety of pyranonaphthoquinones via 
intramolecular alkoxide Michael addition is another important strategy. 
Nanaomycin A has been synthesized using this strategy.3® 
MeO OMe. MeO OMeg 
OMe OMe 
50 51 
MeO OMe. 
IvX^Cl^COzMe 
OMe 
MeO OMe 
C02Me 
1 8  
Benzindene 50 underwent oxidation and Wittig olefination to yield 51. 
Reduction of 51 with sodium borohydride generated an alkoxide which 
underwent conjugate addition to give 52. Ichihara et ai. has reported a synthesis 
of frenoiicin by a similar route.39 The same strategy also was used to build the 
complex carbon framework of (+)-griseusin A.40 
The intramolecular alkoxide Michael addition strategy combined with 
addition of a nucleophile to an activated naphthoquinone is a facile method. 
Naruta and coworkers have reported a total synthesis of the 
pyranonaphthoquinone antibiotics eleutherin, isoeleutherin, nanaomycin A and 
deoxyfrenolicin using this approach.41 
X o o 
Metal 
R2 
O 
53 
X 0R3 0 
ôcX .^. 
0R4 
54 
X 0R3R1 
(W^on 
0R4 
55 
X 0R3 R1 
0R4 
5 6  
The crucial step in the route is a regioselective allylation of an alkoxy 
quinone with allylsilanes or allylstannanes. The allylated products are easily 
converted to pyranonaphthoquinones by intramolecular Michael addition. 
IV. The strategy involving organometallic intermediates 
Using an intramolecular chromium-carbene cycloaddition followed by an 
1 9  
intramolecular alkoxide Michael addition, Semmelhack et al. reported the 
synthesis of deoxyfrenolicin.42 
MeO o O^ 
(^Cr(C0)5l| 
r 
57 
MeO O \ 
MeO O o 
- c&ir 
Cr(C0)3 
58 
MeO 
O^ OH H 11 
O 
59 
l O \ 
rSV° 
o 
60 
South and Liebeskind reported the regiospecific total synthesis of 
(±)-nanaomycin A using a phthaloylcobalt complex.43 
(CH2)5 O 
OSiMe^Bu^ 
CN 
6 1  62 CN 
OSiMegBu^ 
ÔQOL 
O 
63 
20  
A highly functionalized benzocyclobutenedione substituted with a pendant 
alkyne was converted in high yield to a phthaloylcobalt complex which 
underwent regiospecific intramolecular reaction to give macrocyclic 
naphthoquinone 62. Conversion of 62 to nanaomycin A was accomplished in 
three steps involving reductive pyran formation and hydrolysis of a nitrile. 
Another synthesis of pyranonaphthoquinone antibiotics involving 
organometallic intermediates was reported by Semmelhack et al.44 The nickel 
complex underwent conjugate addition to the juglone monoketal derivative 64. 
Enolate trapping provided 65 in high yield. Hydrolysis to the hydroquinone 
followed by reaction of the hydroxyqulnone under alkoxycarbonylation conditions 
provided pyrans 67 which were converted to nanaomycin A and deoxyfrenolicin. 
l.[RfcNi(C0)3rLi 
64 
O O 
65 
MeO O R MeO O R 
OH PdCI^CH,CN)? 
CuCl2 
^ CO/MeOH O 
67 66 
The useful biological activity and unique structure of pyranoquinones have 
prompted considerable synthetic attention. Many elegant syntheses of 
pyranonaphthoquinone antibiotics have been achieved; however, multistep 
21  
sequences for construction of substituted naphthoquinones limit the synthetic 
utility of many routes. 
22  
RESULTS AND DISCUSSION 
As a result of the sophisticated detection and isolation procedures 
developed by Omura^S and others, the family of biologically active 
pyranoquinones continues to grow rapidly. In development of new synthetic 
approaches to these compounds, we were intrigued by the novel photochemical 
reaction show below which had been reported by Otsuki in 1974.46 
O O 
70 71 
R = H, alkyl, a^CHz 
A = alkyl, Ph 
We expected that irradiation of 2-ethoxynaphthoquinone 70 in the presence 
of unsaturated acids might result in a very direct synthetic route to 
pyranonaphthoquinones. There were, however, several unanswered questions 
regarding the stereochemistry of adducts 71, the generality of the photochemical 
reaction and the mechanistic pathway of this unusual reaction. The proposed 
OH R 
o 
72 
23  
biradical intermediate 72 would probably not afford the regiochemical outcome 
which was observed. 
Initially, the reaction of 73 with methyl acrylate was examined. This reaction 
produced mainly polymers with none of the desired ester. 
The analogous reaction with 3-buten-1-ol, however, produced adduct 74 in 
53% yield after chromatography. This adduct appeared to be a single 
stereoisomer, as evidenced by proton NMR and CMR spectral analysis. The 
reaction of 73 with allyl alcohol provided alcohol 75 as a single isomer in 50% 
yield. 
Jones oxidation of 74 and 75 gave acids 76 and 77 in 80% and 85% yield, 
respectively. Acids 76 or 77 should be a natural precursor to pyranonaphthy-
hydroquinones which, in turn, could readily be converted into the 
pyranonaphthoquinones if the reaction gave products similar to the one reported 
by Otsuki.46 However, acids 76 and 77 were recovered after treatment under 
acidic conditions such as PTSA in THF, concentrated HCI in THF, or mild bases 
such as triethylamine in acetonitrile. 
O 
.OCH2CH3 
Polymer 
O 
73 
74 Jones 76 
75 ox. 77 
A = CHfHzOH, CH^OH 
24  
The stability of 76 and 77 to acid and mild base seems unusual, particularly 
since Diels-Alder adducts of benzoquinone can readily be aromatized under 
similar conditions.36 This strange result and the unclear regiochemical analysis 
which was reported by Otsuki prompted us to doubt the photochemical result. 
Although "I H NMR spectrum and the exact mass of 74 and 75 supported the 
structure which had been assigned, the CMR spectra of 74 and 75 indicated 
that structure assignment for these compounds was questionable. Fortunately, 
compound 75 is a highly crystalline solid. X-ray crystallography of compound 
75 gave the structure show below (see Appendix). Because of the similarities 
between the NMR spectra of 74 and 75, the structure of 74 can also be 
OH 
assigned. 
74 CHzCHzOH 
75 CH^OH 
76 CHzCO^ 
77 COjH 
A 
O 
Since the photochemical reaction gave the adducts 74 and 75, it is not 
difficult to understand why acids 76 and 77 did not undergo aromatization. 
25  
The mechanism by which 74 and 75 are formed probably involves a [2+2] 
cycloaddition followed by a type II photocyclization. The [2+2] cycloaddition 
reaction has ample precedent in the photochemistry of quinones.47 The 
formation of a highly strained spirocyclic ring system by a type II photocyclization 
has much less precedent.^® It is probable that the compounds produced by 
Otsuki have the spiro structure of 74 and 75. 
With this interesting but disappointing result, we began to seek a new 
synthetic approach to pyranonaphthoquinones.Previous work from our laboratory 
demonstrated the facile conjugate addition of butenolide anions to unsaturated 
carbonyl compounds.49 Addition of butenolide anions to activated 
naphthoquinones, however, failed to give similar results. 
X " + 
OH O O 
Addition of 2-t-butoxyfuran to activated naphthoquinones gave the Michael 
addition products.36 
26  
MeO O O MeO OH O 
ùy- o - ' —6%: 
O OH O^ 
OBu' 
The reaction of acetylnaphthoquinone with 1-ethoxy-1-t-butyl-
dimethylsilyloxy-butadiene 84 gave cyclization product which was also 
observed by Naruta et al.41 in their studies toward the pyranonaphthoquinones. 
i A T l  Cy + —OCX 
COzEt 
Based on this "undesirable" cyclization, it is clear that the substituents on the 
diene will effect the products of the reaction. The generality of the DARC 
sequence, plus the similarity of 84 to 2-(trimethylsilyloxy)furan 85 suggests that 
85 and activated quinones should undergo a similar reaction. 
^~~y-OSiMe2Bu' ^"^OSiMcj 
OEt ° 
84 85 
2-Butyrylnaphthyhydroquinone 86 was prepared from 
naphthyhydroquinone via a three step sequence. It was further oxided with eerie 
27  
ammonium nitrate (CAN) in acetonitrile and water to give the 2-butyrylnaphtho-
quinone 87. 
OH O 
CI' 
OH 
AICI3 
CH2CI2* 
0 
Et2N 
CH2CI2 
OH O 
O. 
O 
HCI 
EtOH/HjO 
OH O Q O 
CAN 
CH3CN/H2O 
Naphthoquinone 87 is somewhat unstable and in practice it was used 
OH o 
87 + 85 
28  
without additional purification to react with 2-trimethylsilyloxyfuran 85 to give the 
cyclization product 88. Oxidation of 88 with eerie ammonium nitrate gave 
naphthoquinone 89 which was treated with triethylsilane and boron trifluoride 
etherate at -78°C to give 9-deoxyfrenolicin B (10). 
OH 
89 
2. HCI/THF 
10 
To test the generality of this direct route to pyranonaphthoquinone 
antibiotics, different activated naphthoquiones were used. 2-Acetylnaphtho-
quinone 90 gave 9-deoxykalafungin 93 via the same three step sequence. 
8-Methoxy-2-acetylnaphthoquinone 94 also gave the 
pyranonaphthoquinone product 96 which should be easily converted to 
kalafungin. 
29 
9 O OH o 
OTMS 
MeCN 
o OH 
1. Et.SIHH'FA 
. 2. HCimiF 
MeO 9 Q OTMS 
MeCN 
MeO OH o 
MeO O HO 
1 
5 U  
O 
96 
30  
Our new synthetic approach stemmed from careful analysis of the structure 
of pyranonaphthoquinones. Nanaomycin A (3), frenolicin (9), kalafungin (1), 
medermycin (11) mederrhodin (12), and novel C-glycoside SCH 38519 (17) are 
representives of pyranonaphthoquinone antibiotics. They not only show similar 
biological activities, but also have in common the isochromanquinone skeleton 
as was mentioned before. It is clear from an examination of their structures that 
the primary difference lies in the substitution pattern on the naphthoquinone 
subunit. Our interest in developing a common intermediate for all of these 
natural products led us to plan the route shown below. 
A direct route to 100, coupled with the annulation methodology developed 
by Bauman et al.,50 could provide a general synthesis of these 
pyranonaphthoquinone antibiotics. 
It is apparent that the versatile intermediate 100 could be prepared from 
acetylbenzoquinone 101. In fact. 101 reacted with 85 in dichloromethane to 
give the cyclization product 102, which was oxidized with eerie ammonium 
nitrate to the provided hemiketal 103. The compound 100 was obtained by 
reduction of hemiketal 103 using triethylsilane and boron trifluoride etherate. 
100 
31  
O O 
O 
101 
HO ? 
^^OSiMea 
85 
O 
102 
CAN 
O HQ 
o h-l 
o 
EbSm. 100 
BF3'Et20 
103 
Initially, quinone 100 reacted with 1 -trimethylsilyloxy-1,3-butadiene, The 
resulting Diels-Alder adduct was treated with triethylamine, followed by acidic 
work up, to provide 9-deoxykalafungin. 
1 .  
100 
OTMS 
2. EtjN 
3. H+ 
However, we met with difficulty when 100 reacted with 1- methoxy-1-
(trimethylsilyloxy)butadiene under similar conditions. The expected product, 
kalafungin, could not be separated. As a result, a mixture of two regioisomers 
was obtained in low yield. 
3 2  
In order to achieve good regioselectivity, the intermediate 104 was 
prepared. Group X could be a phenylthio group or a halogen atom. 
Hn O 
X 
Introduction of a phenylthio group by treatment of 102 with PhSCI and base 
(EtgN or NaH) did not give the desired product. 
Bromination of o-hydroxyacetylphenol using bromine/TiCi^ has been shown 
to be selective for bromination ortho to the phenol.51 Bromination of 102 with 1 
equivalent of bromine gave the bromination product 105. This result did not 
give us the desired product. However, it did suggest the versatile intermediate 
106, instead of 104. 
0 
104 
HO 9 HO 9 
102 
105 
33  
trn O 
Br 
OMe 
106 
An acid sucli as nanaomycin A can be converted into a lactone in high yield 
under mild conditions.52 Previous worl( in this laboratory has shown that 
activated naphthoquinones react with activated 1,3-butadienes to give cyclization 
products in high yields. We expected that the reaction of acetylbenzoquinone 
with 1 -methoxy-1 -(trimethylsilyioxy)butadiene should give the cyclization product 
also. 
In fact, ester 107 was obtained from acetylbenzoquinone via the one-pot 
Diels-Alder-retro-Claison (DARC) reaction in 91% yield. 
HO 9 
> 101 + 84 
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HO 9 
101 1. 84 
2. F 
91% OMe 
107 
Bromination of 107 with 1 equivalent of bromine afforded only the 
bromophenol 108, as evidenced by TLC and the proton NMR spectrum of the 
unpurified material. Support for the regiochemical assignment came from an 
NOE study of the methyl ether of 108. Irradiation of the methyl group of the ether 
did not cause an enhancement of the aromatic ring proton, which is consistent 
with the stnjcture of 108. 
HO 9 
107 
leq. Brz/TiCl^ 
OMe 
no NOE 108 
OMe 
Interestingly, bromination and oxidation with 2 equivalent of bromine and 
TiCl4 in methylene chloride at 0°C afforded quinone 109 (which can also be 
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made by oxidition of 108 witfi eerie ammonium nitrate) in 82% yield, presumably 
via the intermediaey of bromophenol 108. 
107 2 eg. Brz/TiCl^ CAN 108 
COaMe 
109 
EtgSiH 
CT3CO2H 
O = 
O 
110 
Initially, quinone 109 was treated with 1 -methoxy-1 -(trimethylsilyloxy)-
butadiene at -78°C to afford a complex product mixture as evidenced by thin 
layer chromatography. Fortunately, reductive removal of the hydroxyl group 
provided the quinone 110, which did react to yield 111, an advanced 
intermediate in our previous synthesis of nanaomyein A. 
110 
1  ^VOTMS 
MeO 
2. EtgN 
OH O 
COzMe 
2 steps 
111 
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The sequence 107 - 109 --110 produced a common intermediate by 
which the more complex pyranonaphthoquinones can be prepared. Since highly 
oxygenated dienes are readily available, this extremely convergent approach will 
permit the direct synthesis of biologically active analogues and may also aid in 
the structure identification of quinone natural products. 
Our next effort involved the synthesis of the interesting novel C-glycoside 
SCH 38519 (17). 
Me2N 
17 
In the context of extending the DARC reaction and our three step lactone 
formation strategy, we recognized the need for a synthesis of aryl C-glycosyl 
compounds based on a Michael addition/aldol condensation sequence. This 
sequence would provide an aryl C-glycosyl compound with the phenol group 
meta to the C-glycosyl linkage. In contrast, the synthetic approaches developed 
by Kozikowski et al.,53 Cai and Qiu,54 Hoffmann and Schmidt,55 Martin and 
Horton56 produced the C-glycosyl compound with a phenol in the ortho or para 
position. If such a sequence could be realized, a retrosynthetic analysis for 
compound 17 might be devised as shown below. 
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HO O 
17 
HO»" 
In order to test this question, we reacted the enol silyl ether of 112 with 
acetylbenzoquinone, expecting to obtain a diketone. The product we actually 
isolated in 70% yield was enol silyl ether 113. Surprisingly, all attempts to 
cyclize 114 to a naphthol led to the recovery of 114 (t-BuOK in THF or DMF, 
25°C) or to the decomposition of 114 (t-BuOK in DMF, 60°C: NaOMe/MeOH, 
25°C). 
O Q 
+ EI3N + TMSOTf 
CH2CI2 
112 
OTMS 
% 
113 
O O 
2.,. 1^ 
o 
CH3CN 
r. L 
70.1% 
-78°,0®C 
90% 
OH O 
OTMS 
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However, the deprotection of the enol silyl ether 114 with commercially 
available tetra-n-butylammonium fluoride In methylene chloride unexpectedly 
produced the hydroxyketone 115 in 62% yield. We had anticipated that the 
hydroxyketone would rapidly dehydrate to form the aromatic ring. The structure 
of 115 was supported by OMR resonances at 201.69 and 156.15. The proton 
NMR spectrum exhibited three AB quartets for the three methylene groups in 
115. This reaction has been repeated 3 times with yields ranging from 55% to 
62%, The reaction of hydroxy ketone 115 with acetic anhydride, triethylamine 
and 4-dimethylaminopyridine (DMAP) afforded triacetate 116 (R = COCH3) in 
90% yield. 
OH O OH O 
OTMS 
OH >-< 
BnO O 
r. t, 
55-62% 
O CH2CI2 
n-Bu^N^F" 
O 
114 l i s  
AC2O 
EI3N. DMAP 
CH2CI2 
r. L 
90% 
116 
The conversion of ketone 112 into triacetate 116 demonstrated that the 
Michael addition/aldol condensation sequence was a viable one for the 
generation of C-glycosyl compounds. In compound 17 there are two bonds from 
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117 
1. DMSO, THF 
(COClh 
EtaN * 
2. MeMgBr 
2 steps 
PCC 
CH2CI2' 
118 
o o 
EtaN 
TMSOTf 
CH2CI2 
-78® tor. L 
84% 
OTMS 0* 
^Vv X 
CH3C 
3^0 
N 
r. t. 
55% 
OH O OH O 
n-Bu4N F OTMS 
CH2CI2 
r. t. 
54% 
121 122 
DMAP 
AC2O 
0 0 
EtaN 
• (jl CH2C12 * 
r. t. 
87% 
•^0 0^ 
-Y 
,0. 
•o 
123 
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the carbohydrate unit to the naphthoquinone ring. In the hope of achieving the 
second linkage on a model system which more closely resembled a precursor to 
17, we prepared pyranose 119 from the readily available bis-acetonide 117 by 
a two-pot reaction. The enol silyl ether was then generated by the reaction of 
119 with triethylamine and trimethylsilyl triflate. Enol silyl ether 120 reacted with 
acetylbenzoquinone to afford a 55% isolated yield of adduct 121. This 
compound was treated with tetra-n-butylammonium fluoride in methylene 
chloride to afford keto alcohol 122 in 54% yield. The naphthalene 123 was 
generated by reaction of 122 with acetic anhydride, triethylamine and DMAP in 
87% yield. 
The cyclization of pyranose 123 was examined. Despite extensive 
variation of temperature, Lewis acid (PTSA/MeCN, 25°C to 80°C: SnCI^, 0°C, 
25°C: Amberlite IR-20/THF, 25°C to 70°C) and order of addition, no cyclized 
products such as 124 were obtained. Attempts to selectively cleave the 1,2-
acetonide(Ac20, AcOH, H2SO4) resulted in the decomposition of 123. 
OAc OAc 
Oi/i HO OAc 
124 
The methodology described herein offers an attractive new pathway for the 
synthesis of aromatic C-glycosyl compounds which would be difficult to prepare 
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by previously reported methods. The three-step sequence of Michael addition, 
aldol condensation and aromatization is compatible with a variety of functional 
groups on both the carbohydrate portion and the quinone portion. The 
preparation of the requisite carbohydrate and quinone units for the total synthesis 
of 17 will be continued in this laboratory. 
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EXPERIMENTAL 
Unless otherwise noted, materials were obtained from commercial suppliers 
and were used without purification. THF and diethyl ether were distilled from 
sodium benzophenone ketyl under nitrogen prior to usage. Benzene was 
distilled from lithium aluminum hydride. Dichloromethane was distilled from 
calcium hydride. Unless otherwise noted, all reactions were conducted under an 
argon atmosphere and all organic extracts were dried over anhydrous 
magnesium sulfate. H:EA refers to hexanes:ethyl acetate solvent mixtures for 
TLC. The purity of all title compounds was determined to be >90% by proton 
NMR spectroscopy and/or elemental analysis. Melting points were determined 
on a Fisher-Johns melting point apparatus and are uncorrected. Infrared spectra 
were obtained on an IBM IR-90 Series FT IR spectrophotometer. High field (300 
MHz) proton spectra were obtained with a Nicolet Magnetics Corporation NT-300 
spectrometer. All chemical shifts are reported in 5 relative to tetramethylsilane as 
an internal standard. Coupling constant (J) are reported in Hz. Abbreviations: s 
= singlet, d = doublet, t = triplet, q = quartet, m = multiplet. Carbon-13 NMR 
spectra were determined on a Nicolet NT-300 soectrometer and are reported in 
ppm relative to the central peak of CDCI3 (77.06 ppm). High resolution mass 
spectra were recorded on a Kratos model MS-50 spectrometer. Low-resolution 
mass spectra were recorded on a Finnegan 4023 mass spectrometer. Silica gel 
used for flash chromatography was 230-400 mesh (Kieselgel 60) purchased from 
EM Science. Gravity column chromatography was performed on 60-200 mash 
silica gel purchased from Davison Chemical (WR Grace Inc.). Elemental 
analyses were performed by Galbraith Laboratories, Inc. 
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General Procedure for the Photolysis Experiments 
A solution of 2-ethoxy-1,4-naphthoquinone (1 equiv.) and the alkenol 
(2 equiv.) in benzene (0.05 M) in a quartz tube under a nitrogen atmosphere was 
irradiated until 90% completion using a medium pressure mercury arc lamp. The 
solution was then concentrated in vacuo and purified by chromatography on 
silica gel using 15:10:1 hexanes;ethyl acetate:ethanol. 
ZÉ NMR (CDCI3): 1.387 (d, J = 6.6 Hz. 3 H). 2.198-2.004 (m, 5 H), 2.943 
(m, 1 H), 3.066 (bs, 1 H). 3.507 (m, 1 H). 3.651 (m, 1 H), 3.907 (m, 1 H), 4.726 (s, 
1 H), 4.805 (q, J = 6.3 Hz. 1 H). 8.032-7.410 (m, 4 H). IR (neat) 781,1032,1051, 
1121.1259,1294,1325,1597,1663, 2990, 3290, 3476 cm""!. MS: m/e 256. 
230. 212.197.184, 173,159, 143,128,115, 77. HRMS: m/e for C16H19O4: 
calcd. 275.12834, measured 275.12865. CMR (CHCI3) 197.502, 143.475, 
134.557, 129.106, 128.322, 127.253. 126.019. 88.037, 86.845, 71.860, 61.335, 
48.674, 36.523, 31.943, 24.934,15.156. TLC (20:10:1 H:EA:ethanol) Rf = 0.13. 
Z5 NMR (CDCI3): 1.491 (d, J = 6.3 Hz, 3 H), 1.897 (m, 1 H), 2.096 (m, 1 
H), 2.568 (dd, J = 4.5,3.0 Hz, 1 H), 3.069 (m, 1 H), 3.087 (s, 1 H), 3.550 (m, 1 H), 
3.879 (m, 1 H), 3.990 (m, 1 H). 4.851 (q, J = 6.3 Hz, 1 H), 8.07-7.46 (m, 4 H). IR 
(neat) 762, 785, 1092, 1121, 1283, 1329, 1597, 1663, 2981, 3327, 3431 cm'1. 
MS: m/e 242, 216,198,181.160,143.128.115.105,77. HRMS: m/e for 
C15H14O3: calcd. 242.09430, measured 242.09455. CMR (CHCI3) 196.864, 
143.226, 134.848, 129.743, 128.863, 127.610, 126.173, 89.173, 87.438, 71.304, 
62.227, 48.827, 39.244, 21.259,16.158. TLC (20:10:1 H:EA:ethanol) Rf = 0.16. 
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FurQ[2.3-t?]naphthQ[2.3-d]furan-4-(1-QXQbutyl)-6t?.8.9,9a-tetrahydrQ-5-hydroxy-
8-one 88 
To a solution of 2-butyrylnaphthyhydroquinone (2.3 g, 10 mmol) in 100 ml 
of acetonitrile at room temperature was added eerie ammonium nitrate (12.6 g, 
23 mmol) in 10 ml of water. After 10 minutes, the reaction was complete as 
evidenced by thin layer chromatography. The mixture was poured onto 30 ml of 
pH 7.2 buffer and the aqueus layer extracted twice with methylene chloride. The 
organic layer was dried, filtered and concentrated in vacuo. To the crude 
quinone in 50 ml of dry methylene chloride at -TB^C was added dropwise 2-
trimethylsilyloxyfuran (1.87 g, 12 mmol). After 1 hour, the solvent was removed 
and the crude product chromatographed on silica gel (3:1 hexane : ethyl 
acetate) to afford 1.82 g (58% yield) of keto phenol. 1H NMR (CDCI3): 1.067 (t, 
3 H, J = 7.5 Hz), 1.846 (m. 2 H), 3.008 (dt, 1 H, J = 17.7, 7.2 Hz), 3.179 (d, 2 H, J 
= 3.9Hz), 3.287 (dt. 1 H, J =1 7.7,7.2 Hz). 5.539 (dt, 1 H, J = 6.3, 3.9 Hz), 6.461 
(d, 1 H, J = 6.0 Hz), 7.675 (m, 2 H), 7.933 (m, 2 H), 8.503 (m, 1 H), 14.741 (s, 1 
H). HRMS caled for C18H16O5: calcd. 312.09978, found 312.09966. MS: m/e 
312, 294. 279, 269. 249. 237, 225.196,167,139, 97, 69, 55. IR (neat) 3422, 
2970, 1784, 1761, 1616. 1450. 1335, 1146, 1047, 908 em-1. 
3.3a.5.11b-TetrahydrQ-5-hydrQxy-5-prQpyl-2H-furQ[3.2-b]naphthQ[2.3-d]pyran-
2.6.11-trione 89 
To a slurry of the keto phenol prepared above (1.65 g, 5.29 mmol) in 70 ml 
of acetonitrile at room temperature was added dropwise a solution of eerie 
ammonium nitrate (7.2 g, 13.2 mmol) in 7 ml of water. After 15 minutes the 
solution was poured into pH 7.2 buffer (20 ml) and then diluted with 100 ml of 
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water. The reaction was extracted twice with methylene chloride. The organic 
layer was dried, filtered and concentrated to provide 1.70 g (98% yield) of pure 
quinone. 1H NMR (CDCI3): 0.851 (t, 3 H, J = 7.5 Hz), 1.056 (m, 1 H), 1.387 (m, 
1 H), 1.984 (m, 1 H). 2.316 (m, 1 H), 2.760 (d, 1 H, J = 17.4 Hz), 2.949 (dd. 1 H. J 
= 4.8,17.4 Hz), 3.207 (s, 1 H), 4.887 (dd,1 H,J = 3.0,4.5 Hz), 5.298 (d, 1 H. J = 
2.7 Hz), 7.320 (m, 2 H), 8.148 (m, 2 H). HRMS calcd for CisHieOe: 
328.09469, found 328.09462. MS: m/e 328, 310, 285, 258, 240, 225, 197, 187, 
105, 77, 69, 55. IR: (neat) 3428, 2970, 1771, 1670, 1593, 1285, 1165, 1045, 
893, 735 cm-1. 
9-Deoxvfrenolicin B 10 
To a solution of the quinone prepared above (1.05 g, 3.2 mmol) in 80 ml of 
methylene chloride at -78°C was added triethylsilane (1.10 ml, 6.91 mmol), 
followed by the dropwise addition of boron trifluoride etherate (0.55 ml, 4.5 
mmol). The reaction was stirred at methylene chloride and the aqueous layer 
extracted again with methylene chloride. The organic layer was dried, filtered 
and concentrated. The cmde product was recrystallized from ethyl ether to 
afford 0.85 g (85% yield) of product. 1H NMR (CDCI3); 1.022 (t, 3 H, J = 7.2 Hz), 
1.662 (m, 4 H), 2.709 (d, 1 H, J = 17.7 Hz), 2.968 (dd, 1 H. J = 5.4,17.7 Hz), 
4.630 (dd, 1 H, J = 3.0, 5.1 Hz), 4.910 (dd, 1 H, J = 3.0,10.2 Hz), 5.292 (d, 1 H, J 
= 3.0 Hz), 7.785 (m, 2 H), 8.131 (m, 2 H). HRMS calcd for C18H16O5: 312. 
09978, found 312.09922. MS: m/e 312, 284, 270, 241, 225, 221,197, 115, 105, 
77. IR (film) 2950, 2920, 2850, 1785, 1770, 1650, 1595, 1455, 1355, 1200, 
1150, 890 cm-1. 
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4-Acetvl-5-hvdroxv-6-bromobenzofuran-2-vl acetic acid 105 
The 0.64 ml of TICI4 (1.0 M in CH2CI2) solution was added to a stirred 
solution of the keto phenol 102 (60 mg, 0.256 mmol) in 3 ml of methylene 
chloride, followed by addition of 0.26 ml of 1.0 M bromine in carbon 
tetrachloride. The solution was stirred for 10 min. at room temperature, then 
poured into ice water and stirred rapidly. The aqueous layer was extracted with 
methylene chloride. The organic layer was washed with brine, dried over 
magnesium sulfate. The crude product was chromatographed on silica gel (2:1 
ethyl acetate : hexanes) to afford 66 mg (85% yield) of a yellow solid of 
bromoketone with m.p. 164-166°C. 1H NMR (CD3COCD3): 2.844 (s, 3 H), 3.974 
(s, 2 H), 5.815 (s, 1 H), 7.153 (s, 1 H), 8.073 (s, 1 H). 13.724 (s, 1 H). MS m/e 
314, 312, 299,297, 269,267,145,89,53, 43. HRMS calcd for Ci2H905Br: 
311.96354, found 311.96333. IR: (neat) 3439, 3069, 2920, 1720,1620, 1418, 
1373, 1335, 1221, 1024, 982, 812cm-1. 
Methvl 4-acetvl-2.3-dihvdrQ-5-hvdroxvben2ofuran-2-vl acetate 107 
To a solution of acetylbenzoquinone (2.30 g, 15.3 mmol) in 60 mL of dry 
CH2CI2 at -78°C was added 1 -t-butyldimethylsilyloxy-1 -methoxybutadiene (6.52 
g, 30.6 mmol). The solution was stirred at -78°C for 30 min and then allowed to 
warm to ambient temperature for 1 h. The solution was cooled to 0°C and 40 mL 
of acetonitrile, 20 mL of pH 7.2 phosphate buffer and 35 mL of tetra-n-butyl-
ammonium fluoride (1 M in THF) was added. The solution was allowed to warm 
to ambient temperature and acidified with 3N HCI. The aqueous layer was 
extracted twice with CH2CI2. The combined organic layers were dried, 
concentrated and then purified by flash chromatography using 3:1 hexanes:ethyl 
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acetate to provide 3.49 g (91% yield) of phenol 107. Phenol 107 was a clear 
liquid. HRMS calcd for C13H14O5: 250.08413, found 250.08439. IR (film) 
3020, 1736, 1580,1474, 1215, 827 cm-1 . MS: m/e 250, 219, 177,161,131, 91. 
1H NMR (CDCI3): 2.58 (s, 3 H), 2.72 (dd, J = 16.2, 6.6 Hz. 1 H), 2.91 (dd, J = 
16.2, 6.3 Hz, 1 H), 3.23 (dd, J = 16.2 7.2 Hz, 1 H), 3.71 (dd, J = 16.5,8.7 Hz, 1 H), 
3.74 (s, 3 H), 5.17 (m. 1 H), 6.79 (d, J = 9.0 Hz, 1 H), 6.95 (d, J = 9.0 Hz, 1 H), 
12.16 (s. 1 H). TLC (3:1 H:EA) Rf = 0.30. 
Methvl 4-acetvl-2.3-dihvdro-5-hvdroxv-6-bromoben2ofuran-2-vl acetate 108 
To a solution of phenol 107 (1.50 g, 6.0 mmol) in 30 ml of CH2CI2 at 
room temperature was added 15 ml of a 1.0 M solution of TiCU in CH2CI2, 
followed by bromine (0.948 g, 6.0 mmol). The solution was stirred overnight. 
Cool water (10 mL) was carefully added and the aqueous layer was extracted 
with CH2CI2 . The combined organic layers were washed with saturated 
NaHC03 solution and then with brine. The organic layer was dried and 
concentrated. The crude product was purified by flash chromatography using 
3:1 hexanes: ethyl acetate to provide 1.258 g (63.5% yield) of 108. HRMS 
calcd for CisHiaBrOs: 327.99463, found 327.99398. IR (film) 3069,3022, 
1726,1636,1590, 1433, 1244,1167,1020, 853 cm""!. MS: m/e 330, 328, 297, 
269, 239, 211,176,147,118,91. 1H NMR (CDCI3); 2.61 (s, 3 H), 2.73 (dd, 1 H, 
J = 16.0, 6.6 Hz), 2.90 (dd, 1 H,J = 16.0,6.6 Hz), 3.21 (dd, 1 H, J = 16.0,7.2 Hz), 
3.69 (dd, 1 H, J = 16.5,9.0 Hz), 3.74 (s, 3 H), 5.19 (m, 1 H). 7.25 (s, 1 H), 12.71 
(s, 1 H). TLC (3:1 H:EA) Rf = 0.52. 
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cis-Methvl 7-bromo-3.4 dihvdro-5.8-dioxo-1 -methvl-1 H-2-benzoDvran.3-vl 
acetate 110 
To a solution of phenol 107 (0.75 g, 3.0 mmol) in 15 mL of CH2CI2 at 
25°C was added 10.5 mL of a 1 M solution of TiCU in CH2CI2 , followed by 
bromine (0.948 g, 6.0 mmol). The solution was stirred for 1.5 h. Water (10 mL) 
was carefully added and the aqueous layer was extracted with CH2CI2 . The 
combined organic layers were washed with saturated NaHCOs solution and 
then with brine. The organic layer was dried and concentrated. The crude 
product was purified by flash chromatography using 3:1 hexanes: ethyl acetate 
to provide 0.85 g (82% yield) of 109. HRMS calcd for CisHiaBrOs: 
345.98751, found 345.98707. IR (film) 3425, 3020, 1738, 1674, 1659,1595, 
1439,1267 cm-1. "IHNMR (CDCI3): 1.74 (s, 3 H), 2.25 (dd, 1 H, J = 18.9, 11.1 
Hz), 2.61 (dd, 1 H, J = 15.9, 5.7 Hz), 2.69-2.78 (m, 2 H), 2.97 (s, 1 H), 3.73 (s, 3 
H), 4.46 (m, 1 H), 7.30 (s, 1 H). MS; m/e 346, 344, 328, 284, 269, 255, 227, 224, 
135,103, 82,71,53. TLC (3:1 H:EA) Rf = 0.17. 
In practice, 109 was reduced directly to afford 110. To a solution of 109 
(0.280 g, 0.81 mmol) at -78°C in 8 mL of CH2CI2 was added triethylsilane 
(0.174 g, 1.5 mmol) followed by BF3.Et20 (0.1 mL). After 30 min, the reaction 
was warmed to 25°C and the solvent was removed. The crude product was 
immediately purified by flash chromatograpy using 3:1 hexanes:ethyl acetate to 
afford a 95% yield of 110. Quinone 110 was an oil. HRMS calcd for 
Ci3Hi3Br05: 327.99463, found 327.99502. IR (film) 3061, 2982,1738, 1668, 
1655,1595,1259 cm-1. 1h NMR (CDCI3): 1.47 (d, J = 6.6 Hz, 3 H), 2.24 (ddd, J 
= 18.3,10.4, 4.0 Hz, 1 H), 2.58 (dd, J = 15.8, 5.7 Hz, 1 H), 2.66-2.75 (m, 2 H), 
3.73 (s, 3 H), 3.85-3.94 (m, 1 H), 4.69-4.78 (m, 1 H), 7.26 (s, 1 H). MS: m/e 330, 
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328, 298, 296, 255, 241, 227,176,148,119, 91, 79, 65. TLC (3:1 H:EA) Rf = 
0.17. 
cis-Methvl 3.4-dihvdro-5.10-dioxo-9-hvdroxv-1 -methvl-1 H-naphthor2.3-clDvran-
3-yl acetate 111 
To a solution of 110 (0.098 g, 0.3 mmol) in 5 mL of CH2CI2 was added 
dropwise 1 -trimethylsilyloxy-1 -methoxy-1,3-butadiene (0.103 g, 0.6 mmol). The 
solution was stirred at -78°C for 1 h and then allowed to warm to ambient 
temperature. Triethylamine (0.070 g, 0.7 mmol) was added and the solution was 
stirred for 5 min. The solvent was removed in vacuo and the residue was 
dissolved in acetonitrile. A 5% solution of HF in acetonitrile was added and the 
solution was stirred for 5 min (TLC). The solvent was removed in vacuo and the 
residue was partitioned between water and CH2CI2. The cmde product was 
purified by silica gel chromatography using 5:1 hexanes:ethyl acetate to provide 
0.032 g (34%) of 111. This compound was identical to that produced in our 
previous synthesis. HRMS calcd for Ci 7H10O5: 300.0998, found: 300.0993. 
IR(film) 3018, 2990,1742,1663,1624,1595,1296, 1215 cm-1. NMR 
(CDCI3): 1.54(d, J=6.6 Hz, 3H), 2.34(ddd, J=18.5,10.5,4.0 Hz, 1H), 2.63(dd, 
J=16.5, 5.4 Hz, 1H), 2.75(dd, J=15.6, 7.5 Hz, 1H), 2.88(dt, J=18.3, 2.7 Hz, 1H). 
3.74(s, 3H). 3.91-3.99(m, 1H), 4.86-4.90(m, 1H), 7.71-7.79(m. 1H), 8.04-8.10(m, 
1H). MS: m/e 316, 296, 284, 242, 227, 214,197,168,139, 121,92, 59. 
TLC(3:1 H:EA) Rf=0.47. 
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5-Acetvl-1 •2:3.4-bis-0-n -methvlethvlideneVL-arabinoDvranosQ 119 
To a stirred solution of oxalyl chloride (3.97 g, 31.3 mmol) in 50 mL of THF 
at -78°C was added dimethyl sulfoxide (3.26 g, 41.7 mmol). The solution was 
stirred at -78°C for 30 min. The diacetonide of galactose (5.43 g, 20.9 mmol) in 
20 mL of THF was added. The solution was allowed to warm to 0°C for 30 min 
and then cooled to -78°C. Triethylamine (10.55 g, 104 mmol) was added and the 
solution was allowed to slowly warm to 25°C over 1 h. The solution was then 
cooled to -78°C and MeMgBr (3.0 M, 38.2 mL, 114 mmol) was added dropwise. 
After the reaction had stirred at -78°C for 2 h, it was allowed to warm to 25°C for 4 
h. The solution was cooled to -78°C and quenched by the addition of 3 mL of 
Eton, followed by 20 mL of NH4CI/NH4OH buffer. The reaction mixture was 
poured into 300 mL of NH4CI/NH4OH buffer and extracted twice with 300 mL of 
ether. The organic layer was dried over MgS04 and purified by silica gel 
chromatography with 1:1 H:EA. The purified alcohol 118 was dissolved in 150 
mL of CH2CI2. To this solution was added PCC (9.05 g, 42 mmol). The reaction 
was stirred for 36 h, diluted with ether, filtered and purified by silica gel 
chromatograpy with 2:1 H:EA to provide 5.02 g (88% yield) of ketone 119. 1H 
NMR (CDCI3): 5.645 (d, 1 H, J = 5.1 Hz), 4.639 (dd, 1 H, J = 2.4, 8.7 Hz), 4.557 
(dd, 1 H, J = 2.1,7.5 Hz). 4.363 (dd, 1 H, J = 2.4, 5.1 Hz), 4.168 (d, 1 H, J = 2.1 
Hz), 2.259 (s, 3 H), 1.505 (s, 3 H), 1.448 (s, 3 H), 1.342 (s, 3 H), 1.313 (s, 3 H). IR 
(neat) 1722,1303,1258,1078,1009, 922, 775 cm'l. MS; m/e 272, 257, 229, 
199, 171,155,141, 111, 97, 85, 71. HRMS: m/e for C13H26O6 calcd. 
272.12599, measured 272.12582. TLC (1:1 H:EA) Rf = 0.40. 
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5-M-Trimethvlsilvloxvethenvh-1.2:3.4:bis-0-M-methvlethvlidQneVL-
arabinopyranose 120 
To a solution of 119 (0.650 g, 2.39 mmol) and EtsN (0.315 g, 3.11 mmol) 
in 5 mL of CH2CI2 at 0°C was added trimethylsilyl triflate (0.55 mL, 2.86 mmol). 
The solution was allowed to warm to 25°C over 4 h. The solution was diluted 
with CH2CI2 and poured into brine. The brine was extracted twice with CH2CI2. 
The organic layer was dried and concentrated in vacuo. The resulting oil was 
purified by silica gel chromatograpy with 10:1 H:EA to afford 0.690 g (84% yield) 
of enol silyl ether 120. 
General Procedure for the Enol Silyl Ether Additions to Acetylbenzoquinone 
To a solution of acetylbenzoquinone (2 equiv.) in acetonitrile (0.25 M) at 
25°C was added the enol silyl ether (1 equiv.) dissolved in MeCN. The reaction 
was allowed to stir at 25°C for 8 h. The solvent was removed in vacuo. The 
residue was dissolved in ether and washed with saturated Na2S203. The ether 
layer was dried over MgS04, filtered and concentrated in vacuo. The product 
was purified by silica gel chromatography with 5:1 H:EA to afford the pure 
product. 
5-(2-(2-Ac9tyl-3.6-dihycirQxyphenyl)-1 •trimethylsilylQxyethenyD-l .g-Q-d -
methvlethvlidene^-3-Dhenvlmethoxy-L-threofuranose 114 
1H NMR (CDCI3): 12.185 (s, 1 H), 7.349 (s, 5 H), 6.974 (d, 1 H, J = 9 Hz), 
6.775 (d, 1 H, J = 9 Hz), 5.991 (d. 1 H, J = 3.6 Hz), 4.728 (d. 1 H, J = 9.3 Hz), 
4.630 (d, 1 H, J = 3.6 Hz), 4.548 (d, 1 H, J = 10.8 Hz). 4.544 (d, 1 H, J = 3.3 Hz), 
4.106 (d, 1 H, J = 3.3 Hz), 3.893 (d, 1 H, J = 17.7 Hz). 3.121 (d, 1 H, J = 17.7 Hz), 
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1.549 (s, 3 H), 1.341 (s, 3 H), 0.069 (s, 9 H). IR (oil) 1639, 1464,1620, 1209, 
1126, 982, 937 cm-1. MS: m/e 514, 424, 265, 237, 204,147, 91, 73. HRMS: 
m/e for C27H3408Si calcd. 514.20231, measured 514.20105. CMR (CDCI3) 
204.114, 157.862, 149.569, 137.470, 128.441, 127.987, 127.758, 126.123, 
118.317, 117.335, 112.035, 112.006, 110.205, 105.699, 82.921, 82.651, 81.969, 
73.017, 43.554, 31.083, 26.943, 26.374, 1.461. TLC (5:1 H:EA) Rf = 0.48. 
5-^2-r2-Acetvl-3.6-dihvdroxvDhenvh-1-trimethvlsilvloxvethenvh-1.2:3:4-bis-0-M-
methvIethvlideneVL-arabinopvranose 121 
NMR (CDCI3) 12.200 (s, 1 H), 6.994 (d, 1 H, J = 8.7 Hz), 6.779 (d, 1 H, 
J = 9.0 Hz), 5.523 (d, 1 H,J = 4.8 Hz), 4.678 (dd, 1 H, J = 2.1, 8.1 Hz), 4.477 (dd, 1 
H, J = 1.8, 8.1 Hz), 4.340 (dd, 1 H, J = 2.1,4.8 Hz), 4.042 (d, 1 H, J = 1.8 Hz), 
3.989 (s, 1 H), 1.602 (s, 3 H), 1.502 (s, 3 H), 1.393 (s, 3 H), 1.335 (s, 3 H), 0.153 
(s, 9 H). IR (oil) 3030,1634,1450,1254,1051, 933, 845 cm-1. mS; m/e 494, 
479, 421, 265, 237, 204,164, 73, 59. HRMS: m/e for C24H3409Si calcd. 
494.19722, measured 494.19675. CMR (CDCI3) 204.013, 157.744, 150.119, 
126.145, 118.314, 117.420, 117.115, 110.453, 108.139, 108.933, 108.762, 
96.581, 70.894, 70.485, 69.818, 43.422, 31.031, 26.071, 25.817, 24.892, 24.149, 
I.482. TLC (5:1 H:EA) Rf = 0.33. 
General Procedure for the Aldol Condensation 
To a solution of ketone (1 equiv.) in CH2CI2 (0.1 M) was added tetra-n-
butylammonium fluoride (1.0 M in THF, 1 eq.). The solution was stirred at 25°C 
for 8 h. The solution was concentrated in vacuo. The product was purified by 
chromatography on silica gel with 1:1 H:EA. 
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5-n.2.3.4-Tetrahvdro-2.5.8-trihvdroxv-4-oxo-2-naDhthvl^-1.2-0-f1-
methvlethvlidene\-3-Dhenvlmethoxv-L-threofuranos6 115 
1h NMR (CDCI3): 11.682 (s, 1 H). 7.387 (m. 5 H), 6.819 (d, 1 H, J = 8.7 
Hz). 6.625 (d, 1 H. J = 8.7 Hz), 6.082 (d, 1 H. J = 3.9 Hz), 4.757 (d, 1 H, J = 11.4 
Hz), 4.690 (d, 1 H, J = 3.9 Hz), 4.551 (d, 1 H, J = 11.4 Hz), 4.211 (d, 1 H, J = 3.3 
Hz), 4.010 (d, 1 H, J = 3.3 Hz). 3.500 (dd, 1 H, J = 1.8 Hz). 2.809 (d, 1 H, J = 1.8 
Hz), 2.750 (s, 1 H), 2.702 (d, 1 H, J = 1.8 Hz), 1.472 (s, 3 H), 1.353 (s, 3 H). IR 
(oil) 3460, 2970, 2830,1637,1485,1446,1298,1113, 870, 707 cm-1. MS: m/e 
442, 333, 275, 229,192,129,113, 91,69. HRMS: m/e for C24H26O8 calcd. 
442.16278, measured 442.16250. OMR (CDCI3) 201.690, 156.151. 145.723, 
135.442, 128.985, 128.878, 128.380, 125.153, 124.972, 115.874, 115.620, 
112.006, 101.835, 82.777, 82.118, 81.365, 73.733, 72.252, 47.555, 33.207, 
26.742, 26.186. TLC (1:1 H:EA) Rf = 0.49. 
5-n.2.3.4-Tetrahvdro-2.5.8-trihvdroxv-4-oxQ-2-naphthvn-1.2:3.4-bis-0-n-
methylethylicl9n9}-L-arabinQpyranQS9 122 
1H NMR (CDCI3) 11.737 (s, 1 H), 6.934 (d, 1 H, J = 8.7 Hz), 6.679 (d, 1 H, 
J = 9.0 Hz), 5.648 (d, 1 H, J = 4.8 Hz), 4.629 (dd, 1 H, J = 2.1, 8.1 Hz), 4.506 (dd, 1 
H, J = 2.1, 8.1 Hz), 4.333 (dd, 1 H, J = 2.1, 4.8 Hz), 4.046 (s, 1 H), 3.669 (s, 1 H). 
3.159 (s, 2 H), 3.027 (s, 2 H), 1.510 (s, 3 H), 1.381 (s, 3 H), 1.280 (s, 3 H), 1.124 
(s, 3 H). IR (oil) 3508, 3221,1639,1591, 1462,1375,1167, 771 cm-1. MS: m/e 
422, 407, 364, 346, 288, 204,193,176,150,71, 59. HRMS: m/e for C21H26O9 
calcd. 422.15769, measured 422.15738. OMR (CDCI3) 202.625,156.109, 
146.046, 125.404, 115.795, 115.569, 110.057, 108.884, 96.587, 74.879, 71.345, 
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70.934, 70.342, 68.900, 48.143, 31.999, 25.805, 25.682, 24.834, 23.966. TLC 
(2:1 H:EA) Rf = 0.55. This compound was a yellow solid with m.p. 195-196 OC. 
General Procedure for Aromatization 
To a solution of aldol (1 equlv.) in CH2CI2 (0.1 M) was added EtsN 
(10 equlv), acetic anhydride (8 equiv.) and a small crystal of DMAP. The reaction 
was stirred for 8 h. The solution was diluted with CH2CI2 and poured into brine. 
The brine was extracted twice with CH2CI2. The organic layer was dried and 
concentrated in vacuo. The product was purified by silica gel chromatography 
with 1:1 H:EA. 
5-(4.5.8-Triac9tQxy-2-naphthyl)-1.2-Q-(1-methylethyllden9)-3-phenylmethQxy-L-
threoturanoss 119 
1H NMR (CDCI3) 7.808 (s, 1 H), 7.276 (d, 1 H, J = 8.4 Hz), 7.142 (m, 5 H), 
6.894 (d, 1 H, J = 6.9 Hz), 6.888 (d, 1 H, J = 7.8 Hz), 6.140 (d, 1 H, J = 3.6 Hz), 
5.360 (d, 1 H, J = 3.0 Hz), 4.723 (d, 1 H, J = 3.9 Hz), 4.262 (d, 1 H, J = 12 Hz), 
4.162 (d. 1 H, J = 12 Hz), 4.066 (d, 1 H, J = 3.0 Hz), 2.430 (s, 3 H), 2.400 (s, 3 H). 
2.366 (s, 3 H), 1.569 (s, 3 H), 1.379 (s, 3 H). IR (oil) 3032, 2924, 2854, 1761, 
1614, 1464, 1375, 1202, 951, 1078, 1022, 887, 744, 698 cm'l. MS: m/e 550, 
508, 466, 442, 424, 257, 204, 91. HRMS: m/e for C30H30O10 calcd. 550.18391, 
measured 550.18498. TLC (1:1 H:EA) Rf = 0.46. Aanl. calcd for C30H30O10: 
C, 65.49; H, 5.50. Found: C, 65.48; H, 5.58. This compound was a white solid 
with m.p. 153-154 °C. 
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5-f4.5.8-Triacetoxv-2-naDhthvn-1.2:3.4-bis-0-f1-methvlethvlidene^-L-
arabinopyranose 123 
NMR (CDCI3) 7.327 (s, 1 H). 7.270 (d, 1 H, J = 9.0 Hz), 7.255 (s. 1 H), 
7.084 (d, 1 H, J = 8.1 Hz), 5.730 (d, 1 H, J = 4.8 Hz), 4.997 (s, 1 H), 4.731 (dd, 1 H. 
J = 2.1, 7.8 Hz), 4.476 (d, 1 H, J = 7.8 Hz), 4.420 (dd, 1 H, J = 2.1,4.8 Hz), 2.441 
(s, 3 H), 2.374 (s, 6 H), 1.581 (s, 3 H), 1.434 (s. 3 H), 1.332 (s, 3 H), 1.276 (s, 3 H). 
IR (oil) 1763, 1614, 1460 cm-1. MS: m/e 530, 488, 446, 404, 346, 204, 113, 85, 
59. HRMS: m/e for C27H3O11 calcd. 530.17882, measured 530.17885. TLC 
(1:1 H:EA) Rf = 0.42. Anal, calcd for C27H30O11 : C, 61.17; H, 5.70. Found: C, 
61.16; H, 5.84. This compound was a white solid with m.p. 234-235 °C. 
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APPENDIX 
X-ray Crystal Structure of 75 
Crystal Data 
Formula 
Formula weight 
Space Group 
a, A 
b, A 
c, A 
0, deg 
V, A3 
z 
dco/c, g/cm^ 
Crystal size, mm 
/i(MoKa), cm"' 
Data collection instrument 
Radiation (monochromated in 
incident beam) 
Orientation reflections, 
number, range { 2 6 )  
Temperature, °C. 
Scan method 
Data col. range, 29, deg 
No. unique data, total: 
with > 3ff(F^): 
Number of parameters refined 
R" 
Rf, 
Quality-of-fit indicator^ 
Largest shift/esd, final cycle 
Largest peak, e/A^ 
CisHieO^ 
260.29 
P2i/c 
9.610(2) 
12.625(1) 
10.646(2) 
90.940(9) 
1291.5(3) 
4 
1.339 
0.62 X 0.44 X 0.40 
0.904 
Enraf-Nonius CAD4 
MoKa(A = 0.71073A) 
25, 23.0 < 2 6  <  33.8 
22(1) 
6-26 
4.0-50.0 
2263 
1688 
220 
0.0337 
0.0458 
1.50 
0,01 
0.14(4) 
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Representation of the contents of the unit 
cell. Only the hydroxy1 hydrogen atoms are 
shown, with some of the hydrogen bonding inter­
actions indicated. 
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PART IL 
SYNTHESIS OF DITERPENOID ALKALOIDS 
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INTRODUCTION 
Until now, most bridgehead intermediate chemistry has relied on polar Sn1 
substitution reactions. Less attention has been paid to the radical-mediated 
reaction. Since many polycyclic natural products have bridgehead carbon-
carbon bonds, these radicals should have high utility in the synthesis of natural 
products. 
This manuscript will detail a formal synthesis of modhephene by 
nucleophilic addition/ring contract methodology and a synthesis of the ABDE ring 
system of diterpene alkaloids by a bridgehead radical intermediate. 
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HISTORICAL 
Radical chemistry dates back to 1900 when Gomberg investigated the 
formation and reactions of the triphenylmethyl radical. 1 «2 Deeper insights into 
the formation , structure, and reaction of radicals were elucidated in 1950s and 
1960S.3 Recently, free radical reactions have achieved prominence in organic 
synthesis."^ The mild reaction conditions and the normally high levels of chemo-, 
A EL ]L 
regio-, and stereoselectivity allow radical reactions to serve as powerful tools in 
organic synthesis. However, bridgehead radicals have received much less 
attention compared with alky! radicals. 
Several bridgehead radicals have been generated by the reaction 
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conditions used for other alky! radicals. 
Hyperconjugation, through-space and through-bond interactions, 
nucleophilicity, nucleophilic sustitution and addition of bridgehead radicals have 
been investigated. 
The relative strain energies of brigehead radicals have been investigated by 
molecular mechanics calculations and product analysis.^ 
Large long-range coupling in the ESR spectra of brigehead radicals were 
observed and described in terms of through-space and through-bond 
But). 100 0 
a 50 50 
But) 0 100 
0 100 
(MegSi^zN. 29 71 
Br. 
(MesSi^N. 
0 
3 
100 
97 
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interactions.6.7 Bridgehead radicals of bicyclo[1.1.1] pentane and 
bicyclo[2.1.1]hexane are more readily formed than that from 
bicyclo[2.2.1]heptane (norbornane). This fact was explained by these through-
space and through-bond interactions.8 
It has been established that electrophilicity increases in the series sp3 < sp^ 
< sp. All<yl radicals are in fact nucleophilic and the nucleophilic properties are 
more pronounced when a radical is produced on a secondary rather than on a 
primary carbon atom.9'10 
Tertiary radicals are difficult to investigate because of their tendency to 
undergo disproportionation rather than substitution reactions. Some studies on 
the alkylation of protonated heteroaromatic bases have shown, however, that 
tertiary radicals do effect aromatic substitution and are more nucleophilic than 
secondary radicals. 11 
The nucleophilic character of bridgehead radicals has been largely 
investigated, because a tertiary bridgehead radical would be expected to be of 
higher energy than an aliphatic tertiary radical, moreover, the rigidity of the 
system will block disproportionation. 
When bridgehead free radicals were generated in an equimolar mixture of 
benzene and p-difluorobenzene by the thermal decomposition of the t-
butylperoxyesters of 1-adamantyl, 1-bicyclo[2.2.2]octyl and 1-bicyclo[2.2.1]heptyl 
carboxylic acids, the reactivity of p-difluorobenzene relative to benzene indicated 
that bridgehead radicals possess nucleophilic character. 12 
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R- + ^ • 0 — <r'- 6 
R" = 
Kd. 2.35 2.75 3.10 3.40 0.85 
Further studies indicated that the nucleophilicity of bridgehead radicals 
varies as the ring system changes.''^ 
The reaction of the bridgehead radicals 9,10 and 11 with protonated 
pyridines and quinones showed that the order of their nucleophilic properties is 
9 > 10 > 11. 
10 11 
AlkyI radicals with an odd electron in a hybrid orbital with some s character 
can also be obtained at the bridgehead positions of polycyclic hydrocarbons. 
The relative rates of alkylation of 4-substituted pyridines by t-butyl and 
apocamphyl radicals were compared. 14 
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R RX 
X 4 ï, 
CN 
COCH3 
1890 
144 
11.1 
1 
10.1 
3.7 
1.6 
1 
a 
H 
CI% 
OCH3 
0.15 
0.0054 
0.26 
0.11 
This great difference in selectivity of the two tertiary alkyi radicals must be 
ascribed to their different configuration. The unpaired electron occupies a p 
orbital in t-butyl and a sp3 orbital in the apocamphyl. This difference affects the 
polarity, the polarizability of the radicals, the strength of the bonds formed, and, 
therefore, the nucleophilic character. 14 
Nucleophilic alkyI radicals react with nitroaromatic compounds to give 
substitution products in good yield. This is a synthetically useful example of a 
homolytic aromatic IPSO-Substitution reaction. 15 
+ Ad 
X X X 
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At temperatures above 335 °K, the cubyl radical 2 reacts with greater 
selectivity than the adamantyl radical 9. A study indicated that this unexpected 
order of selectivity is caused only by exceeding the isoselective temperature^ 6 
Adamantane is an attractive substrate for the study of bridgehead 
Intermediates. Although adamantane chemistry mainly focuses on its 
bridgehead cation reactions, a few examples of adamantyl bridgehead radical 
reaction have been observed. 
Introduction of a 2-substitued allyl group to the adamantane bridgehead by 
a radical-mediated reaction was studied."! 7,18,19 
In comparison with 12 and 16, reagent 14 required a significantly lower 
reaction temperature (80°C vs 132°C). 
Introduction of p-functional alkyi and alkenyl groups to the adamantane 
bridgehead was carried out by radical-mediated reactions of 1 -adamantyl 
bromide and iodide with alkenes and alkynes containing electron-withdrawing 
X^SBu' 
COgEl 
COjEt 
15 
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groups in the presence of tri-n-butyltin hydride and AIBN or a zinc-copper 
ethanol/water system.20,21 
X + 
R2 
X 
Br 
Br 
Br 
Br 
I 
Br 
R^ 
H 
H 
H 
CN 
CN 
H 
R^ BusSnH, AffiN Zn/Cu 
CN 80% 
COCH^ 43% 
70% 
CO^I% 0% 
36% 
SOPh 35% 41% 
Introducing alkenyl groups usually gives products in low yield. 
X + R^- .R2 F 
X R^ 
Br H 
R^ n-Bi^SnH, AIBN Zn/Cu 
CN 66% 
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Br H 0% 
I H COjCHS 40% 
Br H C02a% 33% 
Br H Ph 0% 
I H Ph 15% 
Br H Ph 17% 
The electron-withdrawing groups on the alkene and alkyne are necessary, 
because of the nucleophilicity of the adamantyl bridgehead radical. 
An intramolecular reaction of a bridgehead radical was reported in 1985 
from this laboratory.22 
It is worthwhile noting that all the bridgehead radicals studied so far are 
nonfunctionalized. The bridgehead radical of 17 is the first example of a 
functionalized bridgehead radical. 
They also found that^Z an activating group such as a carboethoxy group is 
essential for a successful radical cyclization.23 Without an activated group, only 
n-Bv^SnH, AIBN 
PhH, Reflux 
17 18 
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the reduction product was observed. 
n-Bi^SnH, AIBN 
PhH, Reflux 
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RESULTS AND DISCUSSION 
Until now, most bridgehead intermediate chemistry has relied on polar Sn1 
substitution reactions. Since the bridgehead cation is relatively stable and easily 
generated by a wide variety of methods, less attention has been paid to the 
radical-mediated reaction. 
In order to study the application of bridgehead radical reactions in organic 
synthesis, we will focus on the synthesis of analogs of a polycyclic natural 
product. Since many polycyclic natural products have bridgehead carbon-carbon 
bond connections, these radicals should have high utility. 
OCH3 
CH3CH2 
X)H 
O 
Q 
2 1  
Among the polycyclic natural products there are many diterpene alkaloids 
isolated from the genera Aconitum, Delphinium, Anopterus, and Spiraea.24 
Most of them possess interesting biological activities.25 For example. 
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methyllycaconitine 21 is a Delphinium alkaloid which has been shown to be a 
potent inhibitor of a-bungarotoxin binding to housefly 
heads(Kjnh=2.5x10''0M).26 There are several features which are common to 
these diterpenoid alkaloids, the most obvious being the hexacyclic skeleton 
which is comprised of one seven-membered, three six-membered, and two five-
membered rings. The lettering and numbering systems used for the aconitine-
type and lycoctonine-type skeletons is shown below. 
13 15 
16 
The synthesis of this complex structure is usually approached by a 
convergent pathway. Several researchers, most notable Wiesner,27 
Masamune,28 Nagata et al.,29 and lhara et al.,30 have reported clever 
syntheses of members of this class of compounds. 
Our direct sythetic plan involved a disconnection leading to an AE ring 
system which would be converted into an advanced intermediate via bridgehead 
radical chemistry. Thus, the functionalized [3.3.1]nonane 
azabicyclo[3.3.1 ]nonane system 24 is a key intermediate in our approach. 
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A 
y 
OH 
/ 
O 
COjEt 
24  
77  
To achieve the synthesis of 24, we started from commercially available 
piperidone 25. 
A ? ^och3 
2. ClCOfP^ 
I I 
C02Et C02Et 
25 26 
Piperidone 25 was activated as an enamine, followed by reaction with 
methyl chloroformate to give the ester 26 in 50% isolated yield with 45 % 
recovered starting material. 
The b-keto ester 26 was treated with potassium t-butoxide and allyl bromide 
to give keto ester 27 in quantitative yield. 
KOBu' 
27 
Regioselective addition of hydrogen bromide to the allyl group was 
performed by passing a stream of anhydrous HBr gas through a solution of 27 in 
pentane in the presence of a medium pressure Hg lamp.31 Bromination of 28 
by treatment of compound 28 with phenyltrimethylammonium perbromide 
(PTAB) in dichloromethane32.33 gave dibromo ketoester 29. 
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Br Br 
Br, 
OCH3 PTAB OCH3 
N 
I 
N 
I 
COiEt COzEt 
28 29 
Unfortunately, treatment of 29 with potassium hexamethyldisilazide only 
gave intramolecular 0-alkylation product 30, instead of desired product 31. 
The compound 29 was treated with lithium hexamethyldisilazide to afford 0-
alkylation product also. 
Since the synthesis of compound 31 from 25 did not work, we had to seek 
another synthetic route to key intermediate 24. 
Blicke and McCarty reported^^ that dimethylcyclohexanone-2,6-
dicarboxylate reacted with formaldehyde and aqueous methylamine in methanol 
at room temperature to form dimethyl 3-methyl-3-azabicyclo[3.3.1]nonan-9-one-
1,5-dicarboxylate in 80% yield. 
29 HMSK 
C02Et 
30 31 
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O O O 
CH30 0Œ3 
^LcOzCH] 
2HCH0 
CI^NHz' 
r.t. 80% O 
CHaO^O 
This would provide a direct route to our desired intermediate 24, if 
bromoketo ester 33 were available. 
In fact, 33 was prepared from readily available keto ester 32 in very good 
yield.35,36 The most direct path from 33 to 34 was via a Mannich condensation 
with ethylamine and formaldehyde. Although displacement of the bromide by the 
amine seemed a likely complication, the double Mannich condensation actually 
proceeded very smoothly to generated 34 in 49% isolated yield with 40% 
recovered starting material. 
The success of this important reaction has enabled us to apply our 
bridgehead radical methodology to the synthesis of diterpenoid alkaloids. Based 
on extensive literature precedent in the radical addition area, the intramolecular 
interception of the bridgehead radical appeared to offer the best chance for a 
high-yield connection of 34 with an alkene.37 
OEt 2 HCHO 
EtO^O 
34 32 33 
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V. 
Eiu u 
\ OH 
COjEt 
Towards this goal, bridgehead bromide 34 was added to a THF solution of 
the lithium enolate of 1-acetylcyclohexene at -78°C. The solution was then 
allowed to warm to 0°C. The expected product was the hydroxy ketone. 
Surprisingly, the only product isolated was the novel diketone 35. The 
resonances at 92.986 and 180.126 (corresponding to the beta-diketone unit) in 
the CMR spectrum strongly supported the structural assignment. This product 
presumably arose from enolate addition to the ketone followed by ring 
contraction of the resulting tertiary alkoxide to a 3-azabicyclo[3.3.0]octane 
system. There is little precedent for this nucleophilic addition/ring contraction 
sequence in bridged ring systems. The rearrangement of the bromo ketone 
34 + 
35 
not 
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shown below employed aqueous silver nitrate.38 
aq. 
AgNOg 
O. 
CO2H 
When 34 was treated with phenyl lithium, methyl lithium or the lithium 
enolate of acetophenone, rearrangement products were also observed. 
34 RU 
THF EtO 
0°C 
R % Yield 
36 PhCOCHz 58 
37 Ph 73 
38 Me 53 
In order to determine whether the rearrangement would occur in the all-
carbon framework, keto ester 39 was prepared. The reaction of bromoketone 33 
and methyl vinyl ketone (MVK ) in concentrated sulfuric acid at 0°C generated a 
diketone derived from a Michael addition reaction. This diketone could be 
cyclized to 39 in 77% yield by treatment with concentrated sulfuric acid at 
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MVK O O 
33 
98% H2SO4 I JVoEt 
O 
.(LBr 
O 
Et0"^0 
39 
39 + 
OLi 
THF 
O't 
OX\  O OH 
40 
39 + LiCH2PO(OMe)2 P0(0Me)2 -1 
EtO'^O 
100% 
UOH 
THF 
o / \ o  0  
4 1  
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ambient temperature.39 The reaction of 39 with the lithium enolate of 
acetophenone(-78°C to 0°C) furnished diketone 40 in 41% yield. 
The reaction of 39 with (MeO)2POCH2Li gave a mixture of rearranged and 
unrearranged products in 70% yield. 
The unrearranged product can be completely converted to rearranged 
product 41 by treatment with LiOH in THF. The mechanism of nucleophilic 
addition/ring contraction that we proposed earlier was strongly supported by this 
conversion. 
The bicyclic compound 41 contains two of the three rings of modhephene, 
43, a novel terpene. 
It is clear that this addition/ring contraction sequence could lead to a direct 
route to modhephene. 
We expected catalytic hydrogénation of 41 should produce one isomer by 
reduction from the less hindered exo face. However, catalytic hydrogénation of 
41 with 10% palladium on carbon in ethanol somehow gave completely exo 
isomer 44 in quantitative yield. Cyclization of 44 with potassium hydride and a 
catalytic amount of 18-crown-6 at 80°C in benzene afforded 45. 
43 
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41 — EtO 
Pd/C 
EtOH OEt 
44 45 
Methyl ester 41a was also prepared by the same reaction sequence. 
O O :lbt 
o 
MeO'^O 
39a 
0 / \ 0  9  
41a 
Hydrogénation of 41a with palladium on carbon followed by an 
intramolecular Wittig cyclization gave the Mundy intermediate 45a. This could 
be converted to epimodhephene in 2 steps.^O 
o / \  0  9  
41a 3 J5L 
O 
Pd/C 18-C-6 
EtOH " OMe 
44a 45a 
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Hydrogénation of compound 41a with lr(l) in methylene chloride^l gave the 
exo addition isomer 44b in quantitative yield. Intramolecular Wittig cyclization of 
44b, followed by nucleophilic addition with methyllithium at 60°C in THF gave 
enone 46, the intermediate in Curran's synthesis.42 Compound 46 has been 
converted to modhephene and epimodhephene in one step. 
O 
II 
P(0Me)2 
MeO 
Ir(D 
CH2CI2 
44b 
45b 46 
43 
The comparison of Mundy's and Curran's intermediate with our 
intermediates 45b and 46 is listed below. 
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M: 1.027 (d. 3 H, J = 6.6 Hz) 
Pd/C: 1.032 (d, 3 H, J = 6.3 Hz) 
Ir(I): 1.061 (d, 3H, J = 6.6 Hz) 
C: 1.08 (d, 3 H, J = 6.6) 
A: 1.084 (d, 3 H, J = 6.6) 
M: 0.97 (d, 3 H, J = 6.9) 
M: 5.143 
Pd/C: 5.150 
Ir(I): 5.041 
M: 3.808 
Pd/C: 3.812 
Ir(I): 3.815 
C: 2.05 (d, 3 H. J= 0.96) 
A: 2.054 (d, 3 H, J = 1.2) 
M: 2.08 (d, 3 H, J = 2.6) 
C: 5.66 
A: 5.666 (d, 1 H, J = 0. 
M: 5.81 (d, IH, J = 2.( 
M: Mundy's intermediate 
C: Curran's intermediate 
A: Author's intermediate 
Pd/C: Intermediate was obtained by Pd/C 
catalytic hydrogénation. 
Ir(I): Intermediate was obtained by Ir(I) 
catalytic hydrogénation. 
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The reaction of nucleophiles with bridgehead bromides 34 and 39 affords 
rearrangement products resulting from addition of the nucleophile to the carbonyl 
group followed by ring contraction. This rearrangement reaction is compatible 
with a variety of functional groups. The syntheses of an advanced intermediate 
in the Curran syntheses of modhephene confirmed the structural assignments of 
the rearrangement products. This discovery opened up a new pathway by which 
bicyclo[3.3.0]octanes and their 3-aza counterparts can be constructed. 
In our studies of the rearrangement reaction, we found that the reaction of 
34 with methylmagnesium bromide or allylmagnesium bromide in ethyl ether at 
0°C produced a tertiary alcohol as a mixture of stereoisomers in high yield. This 
result led us to continue to pursue intramolecular bridgehead radical reactions. 
After reaction of compound 48 with trifluoroacetic acid, followed by 
ozonolysis, hydroxy aldehyde 49 was obtained. Irradiation of 49 in benzene 
gave the type II photocycllzation product, 50, as a single isomer as evidenced by 
the proton NMR spectrum. However, X-ray crystal stmcture analysis of its 
hydrochloride salt showed the compound 50 is not our desired product, (see 
Appendix) 
34 + RMgBr 
O't 
47 R = Me 
48 R = CH2CH=CHz 
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48  
1, CI^COzH 
2. 0  ^ \C 
A Br 
N o 
3. M%S, NaHCQ 'H 
EtO^O OH 
Jung and Hudspeth^S have developed a method using the very highly 
reactive compound, 1,1-dimethoxytetrachlorocyclopentadlene as the diene 
component in a Diels-Alder reaction. The remarkable reactivity of this molecule 
in cycloaddition reactions was first recognized by McBee et al.,44 who observed 
that even simple olefins such as allyl alcohol, ally I bromide and indene gave 
good yield of cycloadduct. 
This very highly reactive diene reacted with 48 at 110°C to give the 
cycloaddition products as a diastereoisomeric mixture in very good yield. 
However, when separated diastereoisomers 51 and 51a were treated with 
1.2 equivalents of n-BugSnH and 15 mol% of AIBN in boiling benzene or toluene 
at various concentrations ( 0.1 M and 0.01 M ) individually, the products obtained 
were 52 and 53. Similar results were obtained using photochemistry. 
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N LOH 
^ g E — C02Et 
;.M. 
BugSnSnBug 
hv 
-O o-
ÔH crystal. OH 
BugSnSnBug 
iiv " 
E 
51 
S.M 
51a 
PhH / n-BugSnH 
Reflux AIBN 
PhH\ n-BugSnH 
Reflux^ 
? E OH E (DH 
C l  52 52 
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The reason that ring closure did not occur is not clear. Diels-Alder 
cycloaddition of 1,1-disubstituted cyclopentadienes with olefins usually gives the 
endo isomer.H owever, we were not able to clarify the stereochemistry in our 
multifunctional system. To examine problem, we prepared 54 from 5-bromo-1-
pentene. Since 1,1-dimethoxytetrachloro-pentadiene reacts with 5-
bromopentene, it should give the endo isomer. 
54 
Treatment of 54 with n-BugSnH under thermal conditions did not give a ring 
closure product. 
54 
n-B%SnH / AIBN 
PhH, reflux 
55 
The failure of the ring closure reaction presumably is due to the fact that the 
hydrogen abstraction reaction is much faster than bridgehead radical addition. 
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The intramolecular bridgehead radical reaction did not give the desired ring 
closure product. Considerable attention was devoted to finding another pathway 
for B ring formation. 
Since the double bond on the B ring is necessary for D ring formation, our 
synthesis plan involved B ring formation by an intramolecular aldol or Wittig 
reaction. Introduction of an allyl group on the bridgehead carbon by bridgehead 
radical carbon-carbon bond formation using allylstannanes^S was possible. 
Only one example of allylation at a bridgehead carioon using an allylstannane 
reagent was reported. 19 This approach to carbon-carbon bond formation is very 
general with respect to tolerance of complex functionality. After a functional 
group was introduced by nucleophilic addition to the carbonyl group, ozonolysis 
and intramolecular aldol or Wittig condensation should proceed without difficulty. 
C02Et 
To test this approach, compound 34 was reacted with 2 equivalents of allyl 
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tri-n-butyltin in boiling benzene (0.1 M ) containing 15 mol% of AIBN. The 
allylation product 56 was produced in 84% yield. 
This is the first example of intermolecular bridgehead carbon-carbon bond 
formation by a multifunctionalized bridgehead radical intermediate. To test the 
generality of this bridgehead radical reaction, compound 57 was treated under 
the same reaction conditions. The allylation product 58 was also produced in 
good yield. 
34 + AIBN 
PhH, reflux 
56 
AIBN ^s^SnBugn 
PhH, reflux 
57 58 
56  +  
o o 
OH 
COjEt 
59  
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Reaction of 56 witli suitable nucleopiiiles produced the tertiary alcohol as a 
mixture of stereoisomers in good yield. 
However, ozonolysis of these tertiary alcohols after protection of the tertiary 
amine did not give the desired aldehydes. 
O O 
56 + /ll^P(0Me)2- BuLi O O 
COaEt 
60 
O 
56 + /U^PPh; 
BuLi 
THF 
n 
COjEt 
6 1  
Compound 59 gave diol 62 in low yield. Diol 62 was treated with 
methanesulfonyl chloride and triethylamine giving enol 63, instead of the desired 
diene 64. 
Ozonolysis of compound 60 gave unclear results under the same reaction 
conditions. 
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5 9  
1. CFjCO^ 
2. O3 
Me^S 
3. NaHCOa 
vs 
MsQ 
2Et3N 
-10% overall 
6 2  
not 
1. Cf^CO^H 
' 
Me;^ 
3. NaHCOa 
Ozonolysis of compound 61 under the same reaction conditions gave 
enone 65. Unfortunately, this tricyclic a,b-unsaturated ketone 65 did not give a 
Diels-Alder cycloaddition product. The starting materials were recovered at 
relative low temperature and decomposition products were observed at higher 
temperature due to retro-aldol reaction. 
6 1  
1. CFaCOjH 
2. O3 
MejS 
3. NaHCO) 
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MeO OMe 
CI 
65 
o 
S.M. 
With this pathway closed, we decided to create the D ring first, followed by 
intramolecular aldol condensation to generate the B ring. 
C02Et COjEt 
COaEt 
> 56 
In the event, the direct ozonolysis of compound 56 provided the keto 
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aldehyde 66 in high yield. 
56 
1. CF3CO2H 
2. O3 
MegS 
3. NaHCOj 
However, the reaction of compound 66 with 1-triphenylphosphoranylidene-
2-propanone in boiling benzene did not give a clean Wittig reaction product. The 
hemiketal 67 was obtained. 
6 6  +  
O 
PhH, reflux 
-
O 
COzEt 
+ 67 
68 
When the reaction was carried out in methylene chloride, a mixture of 
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compound 67 and Wittig reaction product 68 was produced. The ratio of 67 
and 68 varied depending on the reaction time and temperature. It is impossible 
to separate these two compounds by flash chromatography, since they have 
exactly the same Rf on TLC. 
Fortunately, we found that compound 67 could be easily converted to 68 in 
quantitative yield by stirring 67 in THF with a catalytic amount of sulfuric acid. 
COzEt 
68 
— S.M. A 
67 
cat. H2SO4 
THF 
68 
ci-l^ci 
MeO OMe 
A 
Decomposed 
CI. 
"rl' a-L\ci 
MeO OMe 
Ultrasonic, r.t. 
S.M. 
98  
The Diels-Alder cycloaddition of 68 was investigated. The reaction of 68 
with cyclopentadiene only gave recovered starting materials even at higher 
temperatures. The reaction with 1,1-dimethoxytetrachlorocyclopentadiene did 
not give the desired product either. 
Eventually, the mixture of 68 and 1-trimethylsilyloxybutadiene in toluene 
was heated to 260°C for 10 hours. The Diels-Alder cycloaddition product was 
obtained as a diastereoisomeric mixture in good yield. 
OTMS 
68 + PhCI% 
260't 
10 h 
C02Et 
69 
+ 
OTMS 
\^ A 
OTMS 
Treatment of the mixture with potassium hexamethyldisilazide in benzene 
from 0°C to rooni temperature afforded the intramolecular aldol cyclization 
product 71. The compound 71 contains the ABDE rings of the hexacyclic 
skeleton of the lycoctonine-type diterpenoid alkaloids. 
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69 + 70 
KN(TMS)2 
PhH 
0°C--r.t. 
COzEt 
71 
In summary, studies on the application of functionalized bridgehead 
radical intermediates in natural products synthesis led us to discover a new 
pathway to bicyclo[3.3.0]octanes and their 3-aza counterparts by nucleophiiic 
addition/ring contraction of bridgehead bromides. The natural product 
modhephene was synthesized by use of this rearrangement methodology. A 
new, highly efficient bridgehead radical intermediate approach to the ABDE ring 
skeleton of lycoctonine-type diterpenoid alkaloids has been developed. The 
facile carbon-carbon bond formation at the bridgehead makes this process 
particularly attractive for the synthesis of polycyclic diterpenoid alkaloid systems. 
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EXPERIMENTAL 
Unless otherwise noted, materials were obtained from commercial suppliers 
and were used without purification. THF and diethyl ether were distilled from 
sodium benzophenone ketyl under nitrogen prior to usage. Benzene was 
distilled from lithium aluminum hydride. Dichloromethane was distilled from 
calcium hydride. Unless otherwise noted, all reactions were conducted under an 
argon atmosphere and all organic extracts were dried over anhydrous 
magnesium sulfate. H:EA refers to hexanesiethyl acetate solvent mixtures for 
TLC. The purity of all title compounds was determined to be >90% by proton 
NMR spectroscopy and/or elemental analysis. Melting points were determined 
on a Fisher-Johns melting point apparatus and are uncorrected. Infrared spectra 
were obtained on an IBM IR-90 Series FT IR spectrophotometer. High field (300 
MHz) proton spectra were obtained with a Nicolet Magnetics Corporation NT-300 
spectrometer. All chemical shifts are reported in S relative to tetramethylsilane as 
an internal standard. Coupling constant (J) are reported in Hz. Abbreviations; s 
= singlet, d = doublet, t = triplet, q = quartet, m = multiplet. Carbon-13 NMR 
spectra were determined on a Nicolet NT-300 soectrometer and are reported in 
ppm relative to the central peak of CDCI3 (77.06 ppm). High resolution mass 
spectra were recorded on a Kratos model MS-50 spectrometer. Low-resolution 
mass spectra were recorded on a Finnegan 4023 mass spectrometer. Silica gel 
used for flash chromatography was 230-400 mesh (Kieselgel 60) purchased from 
EM Science. Gravity column chromatography was performed on 60-200 mash 
silica gel purchased from Davison Chemical (WR Grace Inc.). Elemental 
analyses were performed by Galbraith Laboratories, Inc. 
101 
1-Ethyl-3-methyl-3-allyl-4-piperidone-1 .S-dicarboxylate 27 
To a solution of keto ester 26 (4.0 g, 17.5 mmol) in 30 mL of DMF was 
added potassium t-butoxide (2.35 g, 20.96 mmol). The mixture was stirred for 10 
min followed by the dropwise addition of ally I bromide (3.1 g, 26.25 mmol). The 
reaction was stirred overnight at room temperature, then 50 mL of water was 
added. The resulting mixture was extracted with methylene chloride and then 
washed with water and brine. The crude product was dried, filtered, 
concentrated, and purified by chromatography on silica gel using 3:1 
hexanes:ethyl acetate to afford 4.0 g (85.0% yield) of 27. HRMS calcd for 
C13H19O5N: 269.12633, found: 269.12595. 1H NMR (CDCI3): 1.294 (t. 3 H.J 
= 7.2 Hz), 2.412-2.762 (m, 4 H), 3.215 (d, 2 H, J = 13.8 Hz), 3.369 (m, 1 H), 3.717 
(s, 1 H), 4.187 (q, 2 H, J = 7.2 Hz), 4.526 (d, 1 H, J = 13.2 Hz), 5.116 (m, 2 H), 
5.755 (m, 1 H). MS: 269, 240, 228, 210,196,168, 95. CMR (CDCI3) 203.890, 
170.161, 155.100, 132.068, 119.278, 61.872, 60.951, 52.489, 49.759, 43.383, 
39.683, 36.118, 14.554. IR (neat) 3080, 2982, 2955, 1705, 1433, 1387, 1234, 
1134,1013,926,768 cm-1. TLC (3:1 = H:EA) Rf = 0.28. 
1 -Ethvl-3-methvl-3-^3-bromopropvn-4-piDeridone-1 .S-dicarboxvlate 28 
A solution of unsaturated ketone 27 (4.15 g, 15.43 mmol) in 500 mL of 
pentane was placed in a quartz photochemical reaction vessel and flushed with 
Ng. Then gaseous HBr was passed through the solution for 1 h while the 
solution was irradiated with the light from a medium-pressure Hg lamp. The 
resulting pentane solution was flushed with Ng to remove most of the HBr and 
was washed repeatedly with saturated aqueous NagSgOg, The resulting 
organic solution was dried and concentrated in vacuo to provide 3.67 g (68.0% 
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yield) of bromoketone 28. HRMS Calcd for CigHgoOgNBr: 349.05249, found 
349.05221. 1H NMR (CDCI3): 1.30 (t, 3 H, J = 7.2 Hz). 1.761 -1.968 (m, 4 H), 
2.50 (m, 1 H), 2.716 (m, 1 H), 3.266 (d, 1 H. J = 13.8 Hz), 3.390 (dd, 2 H, J = 6.0, 
5.4 Hz). 3.448 (m, 1 H), 3.745 (s, 3 H) 4.107 (m, 1 H), 4.194 (q. 2 H. J = 7.2 Hz). 
4.459 (dd, 1 H, J = 13.8,1.8 Hz). MS: m/e 351, 349, 322, 320, 306, 304, 292, 
290, 278, 276. CMR (CDCI3) 204.149, 170.307, 154.996, 61.946, 60.780, 
52.536, 50.167, 43.506. 36.498, 33.131, 30.403. 27.857, 14.555. TLC (2:1 
H:EA) Rf = 0.42. 
1 -t^ethvl-3-ethvl 5-bromo-6.3-oxazabicvclQr4.4.0]dec-5-ene-1 .S-dicarboxvlate 
an 
To a solution of dibromoketone 29 (4.16 g, 9.72 mmol) in 60 mL of THF at -
78 oc was added potassium hexamethyldisiliazide solution (2.086 g, 10.5 
mmol). The reaction solution was stirred at -78 for 2 hours and then slowly 
warmed to room temperature for another 2 hours. The reaction solution was 
poured into 50 mL of 0.1 N HCI. The product was extracted with methylene 
chloride, and washed with water and brine. The organic layer was dried, filtered, 
concentrated, and purified by chromatography on silica gel using 3:1 hexanes : 
ethyl acetate to provide 2.63 g (78% yield) of diester. HRMS calcd for 
Cl3Hi805NBr: 347.03684, found 347.03749. 1h NMR (CDCI3): 1.254 (t. 3 H, 
J = 7.2 Hz), 1.385 (m, 1 H), 1.837 (m, 1 H), 2.392 (m. 1 H). 2.915 (m. 1 H). 3.651 
(dd. 1 H, J = 11.1,1.8 Hz), 3.700 (s, 3 H), 3.864 (m, 1 H), 4.127 (q, 2 H, J = 7.2 
Hz), 4.206 (m, 2 H), 4.320-4.722 (m, 2 H). IR (neat) 2986, 2951,1728,1697, 
1475, 1456.1250,1175,1016, 810 cm-1. MS: m/e 349, 347, 320, 318, 290. 
288. 276, 274, 268, 260, 167. CMR (CDCI3) 172.327. 154.568, 147.285, 
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69.357, 61.766, 52.187, 50.768, 50.482, 48.909. 48.469, 29.264, 22.531, 14.514. 
TLC (3:1 H:EA). 
Ethvl 3-ethvl-5-brQmo-9-oxo-3-azabicvclof3.3.1]nonane carboxvlate 34 
To a solution of ethyl 3-bromo-2-oxocyclohexan0 carboxylate (4.98 g, 20 
mmol) in 120 mL of MeOH at 25°C was added formaldehyde (37% in HgO, 3.24 
g, 40 mmol) and ethylamine (70% in H20,1.29 g, 20 mmol). The solution was 
stirred at 25°C for 48 h. The methanol was removed in vacuo and the product 
was taken up in CH2CI2. The solvent was removed in vacuo. The residue was 
purified by chromatography On silica gel using 15:1 H:EA to afford 3.12 g (49% 
yield) of ester 34. The starting ester (1.1 g) was also recovered. The product 
was a colorless oil with Rf = 0.28 in 15:1 H:EA. 1H NMR (CDCI3): 4.232 (q, J = 
7.2. 2 H), 3.602 (dd, J = 2,4,10.8 Hz, 1 H), 3.253 (dd, J = 2.4.11.4 Hz, 1 H), 3.144 
(m, 2 H). 3.033 (dd. J = 2.1,11.7 Hz. 1 H), 2.952 (dd, J = 2.1,11.1 Hz. 1 H). 2.700 
(m. 1 H). 2.570 (m, 1 H), 2.448 (q. J = 7.2, 2 H), 2.560 (m, 1 H), 1.600 (m, 1 H), 
1.299 (t, J = 7.2 Hz, 3 H), 1.117 (t, J = 7.2. 3 H); IR (Det.) 2976,2935, 2814,1730, 
1454, 1258, 700 cm'l ; MS: m/e 319, 317, 302, 300, 274, 272, 238, 220.192, 
164,125,108; HRMS: m/e for Ci3H2o03NBr calcd. 317.06266, measured 
317.06197; CMR (CDCI3) d 201.984, 169.704, 69.738, 68.697. 61.428. 61.097, 
59.835. 50.450, 46.278, 36.270, 22.783, 14.032. 12.488. 
General Procedure for the Nucleophilic Addition/Ring Contraction Reaction 
To a solution of ketone 34 (1.0 equiv.) in THF (0.1 M) at -78°C was added 
the anion (1.1 equiv.). The solution was stirred at -78°C for 10 min and then 
allowed to slowly warm to 0°C over 1 h. Acetic acid in THF was added at 0°C to 
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quench the reaction. Water was added and the aqueous layer was then 
extracted twice with ether. The combined organic layers were dried and 
concentrated in vacuo. The residue was purified by chromatography on silica gel 
with H:EA. 
35: NMR (CDCI3): 15.489 (s, 1 H), 6.862 (s. 1 H), 5.866 (s, 1 H). 3.972 (m, 
2 H). 3.154 (d, J = 9.0 Hz. 1 H), 2.854 (d, J = 9.0 Hz, 1 H), 2.627 (dd, J = 9.0, 2.1 
Hz, 2 H), 2.485 (m, 2 H), 2.223 (m, 6 H), 1.843 (m, 4 H), 1.630 (m, 4 H), 1.116 (t, J 
= 6.6 Hz , 3 H), 1.091 (t, J = 6.6 Hz, 3 H); IR (net) 3383,2935,2802,1730,1641. 
1585, 1448, 1277,1209,1040 cm""!; MS: m/e 361, 344, 316, 288, 270, 252, 209, 
194,164,136,127,109,91,71, 58; HRMS: m/e for C21H31O4N calcd. 
361.22531, measured 361.22518; CMR (CDCI3): 201.343, 180.126, 175.003, 
135.525, 132.955, 92.986, 66.388, 65.114, 64.351, 63.112, 60.423, 49.343, 
39.070, 39.155, 25.822, 25.284, 23.450, 22.019, 21.476, 13.631 ; TLC (1 ;1 H:EA) 
Rf = 0.60. 
36: NMR (CCI3D) : 16.002 (s, 1 H), 7.938 (d, J = 7.2 Hz, 2 H), 7.450 (m, 3 
H), 6.404 (s, 1 H), 3.960 (m, 2 H), 3.238 (d, J = 9.3 Hz, 1 H). 2.937 (d, J = 9.0 Hz, 1 
H), 2.647 (t, J = 9.6 Hz, 2 H), 2.536-2.223 (m, 4 H), 1.882 (m, 4 H), 1.113 (t, J = 6.6 
Hz, 3 H), 1.092 (t, J = 6.6 Hz, 3 H); IR (net) 2968, 2874, 2804,1730, 1610,1574, 
1454, 1279, 768, 694 cm'l ; MS: m/e 357, 340, 312, 284, 252, 210,164, 136, 
105, 71, 58; HRMS: m/e for C21H27O4N calcd. 357.19401, measured 
357.19454; CMR (CCI3D): 201.348, 180.528, 175.128, 134.616, 131.955, 
128.552, 126.743, 94.178, 66.382, 65.255, 64.380, 63.496, 60.694, 49.466, 
39.207, 37.060, 25.396,13.768,13.728; TLC (1:1 H:EA) Rf = 0.38. 
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37: NMR (CDCI3): 7.708 (m, 2 H). 7.432 (m, 3 H). 4.069 (q, J = 7.2 Hz. 2 
H), 3.173 (d. J = 9.0 Hz. 1 H), 2.900 (s. 2 H). 2.823 (d. J = 9.3 Hz, 1 H). 2.472 (m. 2 
H). 2.318 (m. 2 H). 2.171 (m. 1 H), 1.936 (m, 3 H), 1.192 (t. J = 7.2 Hz. 3 H). 1.075 
(t, J = 7.2 Hz. 3 H): IR (neat) 2970. 2874. 2806. 1732. 1678.1600. 1447.1271, 
717, 698 cm-1 ; MS: m/e 315. 298. 272. 242. 226. 210.188.156. 136.105, 77. 
71, 58; HRMS: m/e for C19H25O3N calcd. 315.18344. measured 315.18377; 
CMR (CDCI3): 203.850. 175.646. 137.583. 131.635, 127.987, 127.863, 68.788, 
65.321, 63.847, 62.947, 60.143, 49.535, 40.095, 38.173, 25.577, 13.919,13.551; 
TLC(1:1 H:EA) Rf = 0.38. 
38: NMR (CDCI3): 4.075 (q, J = 7.2 Hz. 2 H), 3.025 (d, J = 9.3 Hz, 1 H), 
2.790 (d. J = 9.0 Hz, 1 H), 2.663 (d. J = 8.4 Hz. 2 H). 2.450 (m. 2 H). 2.236-2.167 
(m, 2 H). 2.134 (d, J = 0.6 Hz, 3 H), 1.821 (m, 4 H), 1.212 (t. J = 6.9 Hz, 3 H), 1.079 
(t, J = 7.5 Hz. 3 H); IR (neat) 2968. 2874,2804,1730,1705,1448,1229,1028, 
932 cm-1 ; MS: m/e 253, 236, 210,180.164. 136,123,108, 80, 71, 58; HRMS: 
m/e for C14H23O3N calcd. 253.16779, measured 253.16716; CMR (CDCI3): 
209.029. 175.305. 69.483, 64.438, 64.003, 62.405, 60.564, 49.387, 39.036. 
37.328. 27.267. 25.163.13.813. 13.548; TLC (1:1 H:EA) Rf = 0.26. 
Methvl 5-Bromo-4-methvl-9-oxo-bicvclor3.3.1]nonane carboxvlate 39a 
Methyl 2-cyclohexanonecarboxylate (4.70 g. 20 mmol) and methyl vinyl 
ketone (2.1 g. 30 mmol) were cooled to -78®C. To this swirled mixture was added 
slowly dropwise 98% H2SO4 (5 mL). The stirred mixture was allowed to slowly 
warm to 0°C. The mixture was then stirred at 25°C for 36 h. The mixture was 
carefuly poured into 200 mL of cold satd. NaHC03. The aqueous layer was 
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extracted with ether three times. The combined organic layers were dried and 
concentrated in vacuo. The residue was purified by chromatography on silica gel 
using 10:1 H:EA to afford 1.98 g (35% yield) of ester 39a. This clear liquid had 
an Rf of 0.38 in 5:1 H:EA. "INMR (CDCI3): 5.748 (1 H, m), 3.784 (3 H, s), 3.350 (1 
H, m). 2.619-2.262 (4 H, m). 2.06-1.89 (5 H, m). 1.716 (1 H, m); IR (neat) 2953, 
2870, 1744,1730,1448,1435,1269,1252, 1130, 1040, 733, 690 cm'l ; MS: m/e 
288, 286, 254, 256, 207,175,147,119,105, 91,77, 65; HRMS: me/for 
Ci2Hi503Br calcd. 288.01854, measured 288.01790; CMR (CDCI3): 199.575, 
170.747, 133.794, 123.598, 75.050, 58.238, 52.194, 43.263, 37.582, 36.892, 
21.704, 20.544. 
Ethvl 5-bromo-4-methvl-9-oxo-bicvclQr3.3.nnonane carboxvlate 39 
Compound 39 was synthesized using the same procedure and reaction 
conditions as used in the synthesis of compound 39a. 1H NMR (CDCI3): 5.751 
(1 H, m), 4.244 (2 H, q, J=7.2 hz), 3.355 (1 H, m), 2.617-2.268 (4 H, m), 2.041-
I.949 (2H,m), 1.920 (3H. s), 1.732-1.659 (1 H, m), 1.303 (3 H, t, J = 7.2 hz); IR 
(neat) 3030, 2986, 2868, 1740, 1718, 1454, 1265, 1254, 1204, 1042, 1028, 690, 
631 cm-1; MS: m/e 302, 300,258, 256,221, 201,175,149,119,105, 91,77, 65; 
HRMS: m/e for Ci 3H1703Br calcd. 300.03611, measured 300.03591 ; CMR 
(CDCI3): 199.554, 170.213, 133.813, 123.675, 75.217, 61.185, 58.078, 43.302, 
37.591, 36.906, 21.706, 20.583, 13.743. 
Ethvl 4-methyl-5-n .a-dioxo-S-phenvn-bicvclofa.a.Oloct-S-envl-l 40 
Compound 40 was prepared using the same procedure and reaction 
conditions as used in the synthesis of compound 36. NMR (CDCI3): 15.906 
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(1 H, s). 7.804 (2 H. d, J=7.5 hz), 7.555 (3 H, m). 6.065 (1 H, s), 5.572 (1 H, s). 
3.979 (2 H, m), 3.438 (1 H, m), 2.311 (3 H, m). 1.849 (4 H, m). 1.567 (3 H, s). 
1.093 (3 H, t, J=6.9 Hz); MS: m/e 340, 294, 266, 220,194,147,121,105, 91, 77, 
65; HRMS: m/e for C21H24O4 calcd. 340.16746, measured 340.16722; CMR 
(CDCI3): 200.265, 179.924, 175.972, 139.505, 134.478, 131.892, 128.500, 
127.292, 126.719, 94.733, 76.704, 63.080, 60.647, 43.100, 42.662, 30.302, 
24.488, 13.699, 13.204. 
Methvl 4-Methvl-5-fdim6thvlphosphonoacetvl)-bicvclQf3.3.0]oct-3-envl-1-
garboxylate 41a 
To a solution of dimethyl methylphosphonate (0.423 g, 3.4 mmol) in 5 mL of 
THF at -78°C was added n-BuLi (1.36 mL, 3.4 mmol). The solution became a 
white suspension which was stin'ed for 15 min. The bromoketone 39a (0.750 g, 
2.62 mmol) in 10 mL of THF was added dropwise. The solution was stirred for 15 
min at -78°C and then allowed to slowly warm to 25''C over 1 h. The solution 
was then cooled to -78°C and quenched with 15 mL of 2N HCI. The aqueous 
layer was extracted four times with 30 mL ether. The combined extracts were 
dried and concentrated in vacuo. The residue was purified by chromatography 
on silica gel using 15:15:1 H:EA:EtOH to afford 0.365 g (49% yield) of ester 41a. 
The ester was a colorless oil with Rf =0.24 in 15:15:1 H:EA:EtOH. 1H NMR 
(CDCI3): 5.610 (1 H, s), 3.790 (3 H, d, J = 11.4 Hz), 3.767 (3 H, d, J = 11.4 Hz), 
3.670 (3 H, s), 3.189 (1 H, m), 3.902 (1 H, m), 2.814 (1 H, m), 2.637 (1 H, m), 
2.233 (2 H, m), 1.905-1.458 (7 H, m); IR (neat) 2959, 2872, 1726,1655, 1439, 
1385,1250,1032, 804 cm'l ; MS: m/e 330,298, 270,179,151,119, 109, 91, 79, 
65; HRMS: m/e for C15H23O6P calcd. 330.12323, measured 330.12270; CMR 
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(CDCI3): 201.554, 201.471, 176.126, 139.091, 128.021, 79.978, 79.908, 62.477, 
52.795, 52.708, 52.447, 52.373, 52.070, 42.900, 42.635, 37.506, 35.646, 30.001. 
23.860, 13.036. 
4-Methoxv-8-methvltricvclof3.3.3.01undec-3-en-2-one 45a 
To a suspension of 10% Pd/C (0.010 g) in 6 mL of MeOH under an 
atmosphere of hydrogen vyas added ester 41a (0.170 g, 0.59 mmol) in 1 mL 
MeOH. The suspension was stirred at ambient temperature for 72 h. The 
suspension was then filtered through Celite with MeOH (do not let catalyst 
become dry!). The methanol solution was concentrated in vacuo. The residue 
was purified by chromatography on 3:3:1 H:EA:EtOH to afford 0.175 g (100% 
yield) of 44a. 1H NMR (CDCI3): 3.814 (3 H, d, J = 10.8 Hz), 3.776 (3 H, d, J = 
11.4 Hz), 3.592 (3 H, s), 3.282 (1 H, dd, J = 16.5,20.1 Hz), 2.986 (1 H, dd, J = 
16.5,19.8 Hz), 2.682 (1 H, m), 2.310-1.480 (10 H, m), 0.972 (3 H, d, J = 6.9 Hz); 
IR (neat) 2956, 2878,1728,1690,1455,1256, 1180, 1135,1030, 870, 805 cm'l; 
MS: m/e 332, 301, 277, 245, 217,151,121,109, 93, 79, 55; HRMS: m/e for 
C15H25O6P calcd. 332.13888, measured 332.13824; TLC (15:15:a H:EA:EtOH) 
Rf = 0.24. 
Compound 44a (0.080 g, 0.28 mmol) and potassium t-butoxide (0.078 g, 
0.70 mmol) and a crystal of 18-crown-6 were heated at 80°C in 5 mL of toluene 
for 15 h. The solution was then cooled to 0°C, water was added and the 
aqueous layer was extracted twice with ether. The combined organic layers 
were dried and concentrated in vacuo. The residue was purified by 
chromatography on silica gel using 5:5:1 H:EA:EtOH to afford 0.023 g (30% yield) 
of compound 45a. 1h NMR (neat): 5.150(1 H, s), 3.812 (3 H, s), 2.1-1.25 (11 H. 
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m), 1.031 (3 H, d, J = 6.6 Hz); IR (neat) 2957, 2876,1715, 1603,1458,1353, 
1228,1141, 830 cm-l ; MS: m/e 206,178,165,152,137,124,105, 91, 77, 65; 
HRMS: m/e for C13H18O2 calcd. 206.13068, measured 206.13042; TLC (5:1 
H:EA) Rf = 0.21. 
4-Methoxv-8-methvltricvclo[3.3.3.0]undec-3-en-2-one 45b 
A solution of ester 41a (0.150 g, 0.45 mmoi) and [lr(COD)(PCy3)(pyr)]PF6 
(0.020 g, 0.025 mmol) in 3 mL of CH2CI2 was charged with an atmosphere of 
hydrogen. The solution was stin-ed for 15 h at 25°C. The solvent was removed in 
vacuo and ether was added. The suspension was passed through a silica gel 
column with 5:5:1 H:EA:EtOH. The cnjde product had been quantitatively 
converted into the bicyclo[3.3.0]octane 44b. NMR (CDCI3): 3.802 (3 H, s), 
3.765 (3 H, s), 3.620 (3 H, s), 3.081 (1 H, d, J = 21.6 Hz), 3.079 (1 H, d, J = 21.3 
Hz), 2.503 (1 H, m), 2.213 (4 H, m), 1.905-1.221 (6 H, m), 0.976 (3 H, d, J = 6.9 
Hz): IR (neat) 2957, 2876, 1726, 1699, 1458, 1267, 1032, 872, 800 cm-1; MS: 
m/e 332, 300, 272, 255,151, 124,109, 94, 79, 67, 55; HRMS: m/e for 
C15H25O6P calcd. 332.13888, measured 332.13840; TLC (15:15:a H:EA:Ethol) 
Rf = 0.24. 
The cnjde product 44b (0.060 g, 0.18 mmol) was dissolved in 5 ml of 
benzene. To this solution was added 18-crown-6 (5 mg) and KH (18.0 mg, 0.42 
mmol). The solution was heated to reflux for 6 h. The solution was cooled, 
washed with water and concentrated in vacuo. The residue was purified by 
chromatography on silica gel using 5:1 H:EA to elute the product and 5:5:1 
H:EA:EtOH to elute the starting material (0.025 g). Chromatography gave 0.020 
g (33% yield) of ketone 45b. ^H NMR (CDCI3): 5.041 (1 H, s), 3.815 (3 H, s). 
110 
2.2-1.25 (11 H, m), 1.066 (3 H. d. J = 6.6 Hz); IR (neat) 2974, 2865,1687,1587, 
1355,1232, 1119, 830, 724 cm'l ; IVIS: m/e 206,178,163, 152,124, 105, 91,77, 
65; HRMS: m/e for C13H18O2 calcd. 206.13068, measured 206.13061; TLC 
(5:1 H:EA) Rf = 0.21. 
4.6-Dimethvltricvclof3.3.3.0]undec-3-en-2-one 46 
To a solution of enone 45b (0.005 g, 0.024 mmol) in 1.5 mL THF at 25°C 
was added MeLi (0.12 mL, 0.15 mmol). The solution was heated to 60°C for 6 h. 
The solution was cooled to 25°C and 1 mL of 2N HCI was added. The reaction 
mixture was stirred for 30 min. The aqueous layer was extracted twice with ether. 
The combined organic layers were dried and concentrated in vacuo. The 
residue was purified by chromatography on silica gel using 5:1 H:EA to afford 
0.003 g (65% yield) of enone 46. The product was a colorless oil with 
Rf = 0.38 in 5:1 H:EA. ^H NMR (CDCI3 ): 5.666 (1 H, d, J = 0.6 Hz), 2.057 (3 H. 
d, J = 1.2 hZ), 1.90-1.18(11 H.m), 1.084 (3 H, d, J = 6.6 Hz); GC-IR 2958, 2878, 
1724, 1618, 1459,1382, 1316,1268, 1128, 865 cm'l; MS: m/e 190,175, 162, 
148, 133,120,105, 91,77, 65; HRMS: m/e for C13H18O calcd. 190.13577, 
measured 190.13553. 
Ethyl 3-ethyl-5-brQmQ-9-hydrQxy-9-(2-QXQ-ethyl)-3-azabicyclQ[3.3.1]nQnane 
carbQxylate 49 
To a solution of alcohol 48 (1.80 g, 5.01 mmol) in 100 mL of methylene 
chloride was added 4.0 mL of trifluoroacetic acid. The mixture was stirred at 
room temperature for 20 min, then cooled to -78°C. Ozone was passed through 
at -78®C until the reaction was completed (solution became blue). Nitrogen was 
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passed into the solution to remove excess O3. Two drops of dimetliyl sulfide 
then were added and the solution was slowly warmed to 0°C. Saturated 
NaHCOg (20 mL) was added to the mixture and then aqueous layer extracted 
with ether. The organic layer was washed with brine, dried and concentrated. 
The crude product was purified by chromatography on silica gel using 15:1 
hexanes:ethyl acetate to provide 750 mg (41.5% yield) of hydroxy aldehyde 49. 
HRMS: calcd for C-|5H2404NBr 361.08887, found 361.08836. MS: m/e 363, 
361, 318, 316, 282, 238, 208, 192, 164,136, 58. NMR: (CDCI3) 1.050 (t, 3 H, 
J = 7.5 Hz), 1.275 (t, 3H, J = 6.9 Hz), 2.064 (m, 2 H), 2.375 (m, 4 H), 2.748-3.378 
(m, 7 H). 4.145 (q, 2 H, J = 6.9 Hz), 5.016 (s, 1 H), 9.973 (t, 1 H, J = 2.4 Hz). IR: 
(neat) 3425, 2978, 2935, 1715,1464,1367,1258,1047, 856, 716 cm'l. 
Tricyclic alcohol $0 
A solution of hydroxy aldehyde 49 (180 mg, 0.5 mmol) in 25 mL benzene in 
a pyrex tube was irradiated using a medium pressure Hg ate lamp for 36 h. The 
solution then was concentrated in vacua and purified by chromatography on 
silica gel using 3:1 hexanes:ethyl acetate to afford 50 mg (27.8% yield) of diol 50 
and 40 mg of 49. HRMS: calcd for Ci5H2404NBr, calcd. 361.08887, found 
361.08877. MS: m/e 363, 361,348, 346, 282, 264, 236, 220, 208, 107, 77, 58. 
1H NMR: (CDCI3) 1.051 (t, 3 H, J = 6.9 Hz), 1.282 (t, 3 H, J = 7.5 Hz), 1.405 ( m, 1 
H), 1.499 (s, 1 H), 1.855 (d, 1 H, J = 15.3 Hz), 2.045-2.446 (m, 6 H), 2.640 (s, 1 H), 
2.816 (m, 2 H), 2.959 (d, 1 H, J = 10.2 Hz), 3.142 (m, 2 H), 3.972 (d, 1 H, J = 7.2 
Hz), 4.187 (q, 2 H, J = 7.2 Hz), 5.212 (s, 1 H); OMR: (CDCI3) 176.547, 80.370, 
77.187, 74.439. 72.826, 61.280, 61.145, 54.923, 51,872, 51.288, 43.906, 
38.662, 28.183,13.950,12.221. IR: (neat) 3456, 2974, 2824,1703,1597,1445, 
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1256, 1060, 974, 858, 706 cm"1. 
Piels-Alder reaction product 51 
To a solution of bromoketone 34 (4.86 g, 15.33 mmol) in 60 mL of ether was 
added allylmagnesium bromide (18.4 mL, 1.0 M in diethyl ether, 18.4 mmol) at -
78°C. The reaction solution was stirred at -78°C for 2 hours and then slowly 
warmed to 0°C for another 2 hours. The reaction solution was acidified with 2 N 
HCI, stirred for 0.5 hour and extracted with ether. The aqueous layer was 
neutralized with saturated NaHCOg and extracted with ether. The crude product 
was dried, concentrated in vacuo to provide 5.03 g (91.5% yield) of allyl alcohol 
48 as a diastereoisomeric mixture. 
The allyl alcohol 48 (1.74 g, 4.85 mmol) and 1,1-
dimethoxytetrachlorocyclopentadiene (1.92 g, 7.28 mmol) were heated at 110°C 
for 14 hours. The crude product was purified by chromatography on silica gel 
using 10:1 hexanesiethyl acetate to provide 980 mg (32.4% yield) of 51 and 1.21 
g (40.04% yield) of another diastereoisomer 51a. HRMS: calcd for 
C23H3205NBrCl4 621.02038, found 621.02180. 1HNMR: (CDCI3) 0.754 (dd, 
1 H. J = 14.7,11.4 Hz), 1.071 (t, 3 H, J = 6.9 Hz), 1.285 (t. 3 H. J = 7.2 Hz), 1.647 
(m, 3 H), 2.142 (dd, 2 H, J = 12.0, 5.7 Hz), 2.354 (m, 5 H), 2.566 (d, 1 H, J = 14.7 
Hz), 2.636 (dd, 1 H, J = 11.7, 8.7 Hz), 2.831 (m, 1 H), 2.944 (m, 2 H), 3.068 (d, 1 
H, J = 12.3 Hz), 3.164 (d, 1 H, J = 11.7 Hz), 3.535 (s, 3 H), 3.583 (s, 3 H), 4.004 
(m, 1 H), 4.223 (m, 1 H), 4.447 (s, 1 H). MS: m/e 623, 621, 574, 572, 492, 490, 
456, 252, 238, 210, 182,136,108, 71,58. IR: (neat) 3477, 2972, 2949,1693, 
1605, 1454, 1196,1119, 911, 773 cm'l. CMR: (CDCI3) 176.851,129.773, 
128.600, 79.322, 74.603, 74.410, 72.946, 64.000, 61.847, 55.227, 54.214, 
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52.335, 51.460, 51.107, 44.825, 38.985, 36.220, 31,105, 23.147, 14.139, 12.330. 
Reduction product 52 
A solution of bromo ester 51 (90 mg, 0.144 mmol), n-BugSnH (49 mg, 
0.17 mmol) and AIBN (3.6 mg, 0.022 mmol) In 2 mL of toluene was heated at 
130°C for 14 hours. Then the solvent was removed. The crude products were 
purified by chromatography on silica gel using 10:1 hexanes:ethyl acetate to 
provide 44 mg (56.1% yield) of reduction product 52. MS: C^NHg) 543. 
1HNMR: (CDCI3) 0.756 (dd. 1 H. J = 14.1,11.1 Hz), 1.054 (t, 3 H, J = 6.9 Hz), 
1.258 (t, 3 H, J = 7.2 Hz), 1.415-1.666 (m, 4 H). 1.744 ( dd, 1 H, J = 12.0, 3.6 Hz), 
1.091 (bs, 1 H), 2.20-2.828 (m, 10 H), 3.065 (d, 1 H, J = 12.0 Hz), 3.533 (s, 3 H), 
3.583 (s, 3 H), 3.771 (s 1 H), 4.160 (m, 2 H). CMR: (CDCI3) 177.328,130.299, 
128.089, 111.304, 79.410, 74.670, 72.834, 61.083, 56.076, 54.907, 52.557, 
51.943, 51.556, 50.174, 43.804, 42.623, 35.005, 34.217, 32.060, 26.085, 20.136, 
14.321, 12.558. 
1.2.3.4-Tetrachloro-7.7-dimethoxv-6-f3-bromopropvhbicvclof2.2.n-2-heDtene 
The 1,1-dimethoxytetrachlorocyclopentadiene (723 mg, 2.73 mmol) and 5-
bromopentene (340 mg, 2.28 mmol) were heated at lOO^C for 16 h. The crude 
product was purified by chromatography on silica gel using 15:1 hexanes;ethyl 
acetate to provide 910 mg (96.8% yield) of 54. H RMS: calcd for 
Cl2Hl502Cl4Br 411.89800, found 411.89839. MS: m/e 414, 412, 377, 255, 
253,197,195,159,115, 59. 1H NMR: (CDCI3) 0.852 (m, 1 H), 1.016 (m, 1 H), 
1.448 (dd, 1 H, J = 11.1,3.2 Hz). 1.836 (m, 3 H), 2.514 (m, 3 H), 3.372 (m, 2 H), 
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3.546 (s, 3 H). 3.592 (s, 3H). CMR: (CDCI3) 129.736. 128.321, 111.530. 78.640, 
74.389, 52.467, 51.389, 46.355, 41.479, 32.721, 30.423. 28.466. IR: (neat) 
2947. 2845. 1605, 1452. 1196, 910, 777, 621 cm'I. 
1.2.3.4-Tetrachloro-7.7-dimethoxv-6-propvlbicvclof2.2.1V2-h6ptene 55 
A solution of bromoketal 54 (200 mg, 0.484 mmol). n-BugSnH (155 mg. 
0.532 mmol) and AIBN (16 mg. 0.097 mmol) In 24 mL of benzene was stirred at 
reflux temperature for 16 h after degasing. Then the solvent was removed. The 
crude product was purified by chromatography on silica gel using 20:1 
hexanes;ethyl acetate to provide 137 mg (85.0% yield) of 55. HRMS: calcdfor 
C12H16O2CI335CI37 333.98749. found 333.98689. MS: m/e 334, 332, 299, 
297, 261. 253. 208,180,159, 75, 59. 1H NMR: (CDCI3) 0.970 (t, 3 H. J = 7.2 
Hz), 1.272 (m, 2 H), 1.444 (dd, 1 H. J = 11.1.3.6 Hz). 1.622 (m. 1 H). 2.486 (m. 3 
H). 3.543 (s, 3 H), 3.590 (s, 3 H). CMR: (CDCI3) 129.547, 128.750, 111.709. 
79.005. 74.730. 52.580. 51.475. 47.030, 41.639, 31.740, 20.421, 14.078. IR: 
(neat) 2957. 2874.1605,1464, 1379,1275, 1198, 1136, 999,781 cm-1. 
Ethvl 5-allvl-3-ethvl-9-oxo-3-azabicvclor3.3.nnonane carboxvlate 56 
A solution of bromoketone (18.43 g. 58 mmol). allyl tri-n butyltin (38.40 g. 
116.0 mmol). and AIBN (1.9 g. 11.6 mmol) in 60 mL of toluene was stirred at 
reflux temperature for 16 h. Then the mixture was cooled to 0°C and 100 mL of 
1.0 N HCI solution was added. The resulting mixture was stirred for 1 h at room 
temperature. After the product was extracted with water, the aqueous phase was 
neutralized with saturated NaHC03 and extracted with ether. The organic layers 
were combined, dried, and concentrated. The ketoester 56 (13.58 g, 84.0% 
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yield) was obtained without additional purification. HRMS: calcd for 
C16H25O3N 279.18344, found 279.18348. Ms: m/e 279, 264, 238, 206, 192, 
170,136, 98, 79, 72, 58. 1H NMR: (CDCI3) 1.090 (t, 3 H, J = 7.2 Hz), 1.288 (t, 3 
h, J = 7.2 Hz), 1.504 (m, 1 H). 1.775 (m, 1 H), 2.172 (m, 4 H), 2.386 (q, 2 H, J = 7.2 
Hz), 2.528 (m, 1 H), 2.922 (m, 3 H), 3.012 (dd, 1 H, J = 2.1,10.8 Hz), 3.189 (dd, 1 
H,J = 2.1,11.4 Hz), 4.212 (q, 2 H, J = 7.2 Hz), 5.022 (m, 2 H), 5.770 (m, 1 H). 
CMR; (CDCI3) 212.479, 171.062, 133.618,116.793, 64.407, 61.574, 60.873, 
58.824, 51.007, 48.719, 39.235, 39.102, 36.721, 20.253,14.014,12.545. IR; 
(neat) 2974, 2929, 2772,1737, 1716,1292, 1097,1007, 915 cm'l. 
1-allvl-2-methvl-3-oxobicvclof3.3.1]nQnane 58 
A solution of bromoketone 57 (210 mg, 0.913 mmol), allyl tri-n butyltin (605 
mg, 1.83 mmol), and AIBN (30 mg, 0.18 mmol) in 1 mL of benzene was stirred at 
reflux temperature for 10 h after degasing. The reaction solution was cooled and 
the solvent was removed. The crude product was purified by chromatography on 
silica gel using 5:1 hexanes:ethyl acetate to provide 120 mg (68.6% yield) of 
compound 58. HRMS: calcd for C13H20O 192.15142, found 192.15141. MS; 
m/e 192,151,109,86, 67.55. 1H NMR: (CDCI3) 1.040 (d, 3 H, J = 6.9 Hz), 
I.162 (m, 1 H), 1.410-1.690 (m, 3 H), 1.929 (m, 2 H), 2.120 (m, 3 H), 2.309-2.506 
(m, 5 H), 5.089 (m, 2 H), 5.820 (m, 1 H). IR: (neat) 3069, 2978,2921, 2878, 
1700, 1635, 1445, 1375, 1190, 995, 905 cm'l. 
Ethvl 3-ethvl-5-^2-Qxoethvn-9-Qxo-3-azabicvclor3.3.nnonane carboxvlate 66 
Trifluoroacetic acid (98 mg, 0.86 mmol) was added to asolution of ketoester 
56 (200 mg, 0.72 mmol) in 20 mL of methylene chloride. The mixture was stirred 
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for 10 min at room temperature, then cooled to-78°C. Ozone was passed 
through at -78°C until the reaction was completed (solution became blue); then 
nitrogen was passed into the solution to remove excess O3. Then two drops of 
dimethyl sulfide was added. The solution was slowly warmed to 0°C and 5.0 mL 
of saturated NaHCOg was added. The product was extracted with ether, washed 
with brine, dried and concentrated. The crude product was purified by 
chromatography on silica gel using 4:1 hexanesiethyl acetate. Pure 
ketoaldehyde 66 (190 mg) was obtained in 94% yield. HRMS: calcd for 
C15H23O4N 281.16271, found 281.16325. MS: m/e 281, 252, 238, 195, 167, 
136,93,71,58. 1H NMR: (CDCI3) 1.103 (t, 3 H, J = 7.2 Hz), 1.291 (t, 3 H, J = 7.2 
Hz), 1.951 (m, 1 H), 2.422 (m, 9 H), 2.935 (m. 2 H), 3.173 (m, 2 H), 4.221 (q, 2 H, J 
= 7.2 Hz), 9.810 (s, 1 H). CMR: (CDCI3) 211.357, 200.441,170.487, 64.448, 
61.321, 60.953, 58.424, 50.672, 49.201, 47.712, 39.670, 36.417, 20.186,13.906, 
12.359. IR: (neat) 2973, 2930, 2813,1733,1716,1455, 1366,1258 cm""!. TLC: 
(4:1 H:EA) Rf = 0.31. 
Tricyclic hemiKetal 67 
To a solution of ketoaldehyde 66 (1.85 g, 6.58 mmol) in 150 mL of benzene 
was added 1-triphenylphosphoranylidene-2-propanone (2.51 g, 7.90 mmol). 
The reaction mixture was heated at reflux in benzene for 36 h. After removing the 
benzene, 150 mL of ether was added. The suspension was filtered, and the 
ether solution was acidified with 2 N HCI, and extracted with ether. The aqueous 
layer was neutralized with saturated NaHCOg and extracted with ether. The 
crude product was dried, concentrated, and purified by chromatography on silica 
gel using 5:1 hexanes:ethyl acetate to provide 1.83 g (82.0% yield) of hemiketal 
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67. HRMS: calcd for Ci 8H29O5N 339.20457, found 339.20406. MS: m/e 339, 
321,296, 278,264, 252, 238, 220,116,136, 71, 58, 1H NMR: (CDCI3) 1.036 (t, 
3 H, J = 7.2 Hz), 1.266 (t, 3 H, J = 7.2 Hz), 1.870-1.483 (m, 7 H), 1.983 (dd, 1 H, J 
= 11.4,2.1 Hz), 2.164 (s, 3 H), 2.264 (m, 2 H), 2.455 (dd, 1 H, J = 11.1, 2.1 Hz), 
2.680 (m, 3 H), 3.056 (m, 2 H), 4.170 (m, 2 H), 4.531 (m, 1 H), 5.123 (s, 1 H). 
CMR: (CDCI3) 207.766 (s). 175.976 (s), 103.623 (s), 73.843 (d), 60.975 (t), 
60.546 (t), 55.834 (t), 52.138 (t),51.551 (t), 49.173 (s), 45. 502 (s), 40.078 (t), 
34.100 (t), 32.007 (t), 30.958 (q), 21.237 (t),13.912 (q), 12.481 (q). IR: (neat) 
3441, 2970, 2933, 1732,1711, 1700, 1557, 1455, 1263, 1079, 1038, 955, 871 
cm""'. 
Ethvl 3-ethvl-5-r4-oxQ-2-Dentenvn-3-a2abicvclof3.3.11nonanQ carboxvlate 68 
To a solution of hemiketal 67 (200 mg, 0.59 mmol) in 25 mL of THF at 25°C 
was added 10 drop of concentrated sulfuric acid with stirring. The solution was 
stirred overnight at room temperature and then added to 10 mL of 2 N NaOH 
solution. The resulting mixture was stirred for 5 min extracted with ether and 
washed with water. Organic layer was dried, filtered and concentrated in vacuo 
to provide 189 mg (100% yield) of pure diketone 68. HRMS: calcd for 
C18H27O4N 321.19401, found 321.19374. MS: m/e 321, 278, 252, 220,192, 
147,136, 71, 58. 1H NMR (CDCI3) 1.092 (t.3 H, J = 7.2 Hz), 1.299 (t, 3 H, J = 7.2 
Hz), 1.800 (m, 1 H), 2.247 (s, 3 H), 2.290 (m, 7 H), 2.969 (m, 2 H), 3.210 (m, 1 H), 
4.236 (q, 2 H, J = 7.2 Hz), 6.047 (d, 1 H, J = 15.9 Hz), 6.806 (dt, 1 H, J = 15.8, 7.8 
Hz). IR (neat) 2973, 2931, 2811, 1732, 1713, 1674, 1454, 1362, 1257, 1176, 
986, 877 cm-1. CMR (CDCI3) 211.975, 198.140, 170.867, 143.495, 134.043, 
64.710, 61.514, 61.132, 58.873, 51.000, 49.427, 39.625, 38.161, 26.743, 26.954, 
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20.314, 14.101, 12.585. 
Tetracyclic Ketone 71 
To a solution of diketone 68 (1.10 g, 3.43 mmol) in 2 mL of toluene 
was added 1-(trimethylsilyloxy)-1,3-butadiene (1.22 g, 8.55 mmol). The 
solution was heated at 260°C for 10 hours. Then the solvent was removed. The 
crude product was purified by chromatography on silica gel using 10:1 
hexanes:ethyl acetate to provided 1.12 g (70.57% yield) of a diastereoisomeric 
mixture of 69 and 70. HRMS; calcd for CgsH^iNOgSi 483.27540, found 
463.27562. 
To a solution 69 and 70 (70 mg, 0.15 mmol) in 3 mL of benzene at 0°C was 
added dropwise a solution of potassium hexamethyldisiliazide in toluene (504 
mg, 15% in toluene, 0.38 mmol). After stirring for 10 min in a cool water bath and 
then slowly warming to room temperature for another 10 min, 1 mL of 2 N HCI 
was added to the reaction mixture at 0°C. Stirring was continued for 5 minutes. 
The resulting solution was extracted with water. The aqueous layer was 
neutralized with saturated NaHCOg and extracted with ether. The crude product 
was dried, filtered, concentrated and purified by chromatography on silica gel 
using 3:1 hexanes : ethyl acetate to provide 38 mg (67.8 % yield) of 71. HRMS 
calcd for C22H31NO4 373.22444, found 373.22531. 1H NMR (CDCI3) 1.042 
(m, 4 H), 1.296 (t. 3 H, J = 6.3 Hz), 1.527 (m. 2 H), 1.791 (m, 2 H). 2.120 (m, 1 H), 
2.305 (m, 5 H), 2.540 (m, 1 H), 2.771 (m, 4 H), 2.940 (m, 1 H), 3.280 (m, 1 H), 
3.416 (d, 1 H, J = 13.2 Hz), 4.210 (q, 2 H. J = 6.9 Hz), 4.535 (s, 1 H), 5.595 (m, 2 
H), 6.973 (s, 1 H). MS; m/e 373, 354,326, 298, 280, 252, 220,195,165,105, 91, 
72, 58. IR: (neat) 3466, 2978, 2934, 1732,1697, 1666, 1458, 1393, 1261, 1022, 
119 
1022, 911, 700 cm-1. CMR (CDCI3) 198.343, 176.343, 137.375, 133.585, 
130.572, 122.346, 73.793, 61.578, 61.070, 56.904, 52.714, 51.845, 48.079, 
44.719, 40.576, 33.042, 30.967, 30.121, 27.061. 19.897, 14.201, 12.563. 
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APPENDIX 
X-ray Crystal Structure of 50 (Hydrochloride Salt) 
Crystal Data 
Empirical Formula 
Formula Weight 
Crystal Color, Habit 
Crystal Dimensions (mm) 
Crystal System 
No. Reflections Used for Unit 
Cell Determination (20 range) 
Omega Scan Peak Width 
at Half-height 
Lattice Parameters: 
a 
b 
c 
Space Group 
Z value 
^calc 
^000 
2"2 
[BrCigNiO^Hg^lCl • CClpH 
481.64 
transparent, cube 
0.500 X 0.500 X 0.500 
orthorhombic 
25 ( 14.0 - 35.0") 
0.43 
J*(HoKo) 
13.250(4)Â 
16.144(6)Â 
9.570(4)A 
2047(1)Â' 
P2i2,2, (#19) 
4 
1.563 g/cm' 
984 
24.01 cm"' 
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